Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16135,166,0.85 [0.35-2.05],0.7135536476467939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,15661,160,1.08 [0.81-1.45],0.5917002617735695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18466,193,1.15 [0.92-1.45],0.2224251218134808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,15585,161,0.51 [0.32-0.81],0.0039695691747093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,18348,192,1.14 [0.91-1.43],0.2403706901205976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,18466,193,1.06 [0.88-1.28],0.5316050631361853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,16132,167,0.99 [0.89-1.09],0.7870255631978503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,15585,161,0.98 [0.78-1.24],0.893482267904435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18138,192,0.91 [0.77-1.07],0.2383876519053299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15833,164,0.90 [0.71-1.16],0.4244425445275824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",16113,168,0.99 [0.84-1.17],0.9109344151596236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,18364,198,1.03 [0.65-1.65],0.8955269230597684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,16132,167,0.81 [0.48-1.38],0.4371721061785775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,18233,194,0.84 [0.65-1.08],0.1819326634174155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,15754,159,1.09 [0.70-1.71],0.6908353436215677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,16059,167,1.04 [0.91-1.18],0.5546084668395872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18563,201,0.89 [0.69-1.15],0.3646226185276815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,15627,160,1.10 [0.80-1.51],0.558692632854138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,18639,200,1.01 [0.69-1.48],0.9637121913615828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,18714,201,0.96 [0.80-1.14],0.6289895628887705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,16057,169,0.98 [0.68-1.42],0.9138646310036284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,15627,160,0.93 [0.80-1.08],0.3301965055988554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,15585,161,0.93 [0.60-1.45],0.7442492037788349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",18233,194,1.21 [0.93-1.58],0.1617248799852001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,15585,161,1.14 [0.90-1.43],0.2735797177137525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,18250,194,0.95 [0.63-1.42],0.7976188630679976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,18371,192,1.68 [1.03-2.75],0.0392179389138856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,18563,201,0.85 [0.69-1.05],0.1270073971004008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15585,161,0.89 [0.67-1.18],0.4070312157361402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,15706,159,1.21 [0.96-1.52],0.1052865560907826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,18783,201,1.05 [0.74-1.47],0.7973658667493426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,18479,198,0.90 [0.67-1.21],0.4878445713640724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15627,160,1.50 [0.98-2.28],0.0593291743629071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18233,194,0.88 [0.59-1.33],0.5586204739118161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18405,192,1.32 [0.92-1.90],0.1265322471789023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18783,201,1.30 [0.89-1.88],0.1736696195439321
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18697,201,1.15 [0.74-1.78],0.53623778369344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16059,167,1.25 [0.76-2.04],0.3831131229767806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15627,160,1.13 [0.71-1.80],0.6160924296175385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18792,201,0.86 [0.51-1.46],0.5859671598640701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18466,193,1.13 [0.82-1.57],0.4445364969489093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18233,194,0.73 [0.46-1.15],0.1695173415186117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15627,160,1.29 [0.86-1.92],0.2178618333424595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18603,198,0.89 [0.68-1.17],0.4192214378795194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,16119,165,0.96 [0.61-1.51],0.8561826570364546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,15661,160,1.54 [0.83-2.84],0.1714417142447888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,16113,168,0.96 [0.66-1.39],0.8143911470003183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,18138,192,1.06 [0.75-1.52],0.7289898350099129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,15754,159,1.13 [0.91-1.41],0.2547661013690228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,18371,192,1.23 [0.84-1.80],0.2888814474464785
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,15754,159,1.03 [0.70-1.52],0.8743226394620147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,16059,167,1.26 [0.96-1.65],0.0964763282590541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18620,198,1.17 [0.75-1.82],0.4857905944751127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18702,201,1.06 [0.71-1.59],0.7807591621712588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,16113,168,0.94 [0.53-1.64],0.823231132374865
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,18466,193,0.95 [0.81-1.10],0.4768022381410668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,18563,201,0.97 [0.60-1.55],0.8961251912159003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,15625,163,0.85 [0.67-1.09],0.2087082216372143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,15754,159,0.93 [0.75-1.14],0.4806260897500638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18233,194,0.88 [0.75-1.03],0.1088942337094126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,16135,166,1.13 [0.91-1.40],0.2799301513631526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,18737,201,1.38 [0.83-2.29],0.2118819562525818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,15585,161,1.04 [0.85-1.28],0.6814290758077712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,15754,159,1.04 [0.86-1.24],0.6971713222339802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFM,Afamin,16135,166,1.06 [0.51-2.20],0.8799286819568919
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,18338,192,1.12 [0.92-1.37],0.2582358009470766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,15625,163,1.12 [0.95-1.33],0.1721600133819747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,18499,197,0.93 [0.68-1.28],0.6514678987252527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,18030,192,1.05 [0.92-1.20],0.5024746648754629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,18111,191,1.07 [0.86-1.32],0.5621658311748209
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,18620,198,0.94 [0.65-1.38],0.7580249314868184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,18783,201,1.08 [0.84-1.38],0.5607405400120618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,16132,167,0.74 [0.35-1.57],0.4387169725013832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,18563,201,0.96 [0.81-1.14],0.6711828485053645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,18563,201,1.02 [0.84-1.22],0.8683870667465501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15661,160,0.82 [0.50-1.36],0.439019055426421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,15661,160,0.83 [0.50-1.41],0.4976042643837927
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,16057,169,1.01 [0.81-1.26],0.9271039341273528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,16132,167,0.95 [0.56-1.64],0.8626191149399702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,18523,199,1.05 [0.90-1.23],0.5441669776077603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",15701,162,1.01 [0.85-1.20],0.9071292412140652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,18138,192,1.21 [0.95-1.53],0.1281743049694742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,15661,160,1.03 [0.78-1.36],0.8343941940326057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18442,192,1.04 [0.93-1.18],0.4795486628639804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,18563,201,1.04 [0.85-1.26],0.7185629020982959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",16084,168,1.13 [0.98-1.29],0.0930321661160648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,15754,159,0.81 [0.37-1.74],0.5873605312307589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,18138,192,1.16 [0.97-1.37],0.0955474010516833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,15701,162,0.79 [0.61-1.03],0.0817696086351442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,18233,194,0.95 [0.73-1.25],0.7217385744448732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,15627,160,0.81 [0.63-1.04],0.0971516134759062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,18163,194,1.04 [0.86-1.27],0.6887747083307372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,16091,168,1.07 [0.95-1.20],0.2463412944692672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,18052,192,1.17 [0.93-1.46],0.1740263146287521
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18792,201,1.31 [0.68-2.49],0.4202117837189177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,18561,199,0.95 [0.75-1.20],0.6662020441743168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",16057,169,1.04 [0.79-1.37],0.7916558171915462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18522,197,0.98 [0.81-1.18],0.7962495529270314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",16091,168,1.07 [0.79-1.46],0.657748419042063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,15833,164,0.78 [0.53-1.15],0.2044228752937454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,15627,160,1.10 [0.98-1.24],0.1007475719488562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",18466,193,0.95 [0.84-1.07],0.3951039746469124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,18250,194,1.33 [0.89-1.98],0.166858617885028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,18710,200,1.33 [0.71-2.51],0.3790936931264336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,16119,165,0.97 [0.55-1.71],0.9074390297839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,18163,194,1.11 [0.92-1.34],0.2659683209965559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,15701,162,1.39 [1.12-1.72],0.002843946663914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,18466,193,1.18 [0.68-2.03],0.5567637430220874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,18250,194,0.97 [0.74-1.27],0.8002474613569445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,15754,159,1.33 [0.89-1.98],0.1626171355874295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,15991,169,1.13 [0.86-1.48],0.3917545380825578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,16084,168,1.13 [0.92-1.38],0.2609119348713388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15108,159,0.86 [0.63-1.19],0.3729775986902182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,17887,193,0.97 [0.74-1.26],0.8046798984918561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,17324,183,0.92 [0.70-1.20],0.5261862084665485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,18536,198,0.79 [0.53-1.17],0.2468624446204689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,18483,197,1.04 [0.89-1.21],0.6315788791389425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,18737,201,0.91 [0.64-1.28],0.5724524804977014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,18281,197,1.12 [0.72-1.75],0.6052259900632843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,18551,197,1.03 [0.74-1.42],0.8658437409776265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,18595,198,0.92 [0.64-1.33],0.6515459619685504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,18598,197,0.97 [0.73-1.30],0.8628300068272817
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,18737,201,1.45 [1.03-2.04],0.0343495724023256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,15585,161,0.79 [0.61-1.03],0.0795516044382775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15627,160,1.14 [0.94-1.37],0.1778509049353283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,15554,161,1.38 [1.10-1.74],0.0048017972148263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,18138,192,0.96 [0.76-1.21],0.7296114387450654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15661,160,0.98 [0.67-1.45],0.9334979584141592
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,18624,198,0.88 [0.55-1.41],0.5915562853050373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,15675,159,1.01 [0.72-1.44],0.9354616609969058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,18163,194,1.06 [0.91-1.24],0.4345063316576295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,18515,196,1.06 [0.88-1.29],0.5408708839040761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15435,157,1.06 [0.86-1.31],0.5891864344691066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,18697,201,1.11 [0.93-1.32],0.2568120486619063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,18480,197,1.01 [0.85-1.21],0.8964182592527434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,18099,193,1.12 [0.73-1.71],0.6061092239829077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],18250,194,1.00 [0.79-1.26],0.9902553057146082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,18649,198,0.77 [0.50-1.19],0.2421496782439699
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,16057,169,1.11 [0.93-1.33],0.2558257776466994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,15701,162,1.26 [0.94-1.68],0.1288274333575643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,16059,167,1.15 [0.95-1.39],0.1452190863018949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,16084,168,1.20 [0.89-1.61],0.2269361981141468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18466,193,1.26 [0.99-1.62],0.062353679506529
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,15990,165,0.95 [0.60-1.51],0.8168438037698447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18684,199,1.16 [0.95-1.42],0.1508533228673395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,18563,201,0.84 [0.66-1.08],0.1807500892040234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,16135,166,1.48 [0.91-2.39],0.1112784588790877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,16132,167,1.09 [0.81-1.48],0.5615706595735455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,16135,166,1.21 [0.80-1.84],0.3726122098891509
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,16132,167,0.90 [0.48-1.70],0.7458106766102779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,15661,160,1.04 [0.73-1.49],0.8264531757204874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,16110,166,1.35 [0.94-1.94],0.1070362484194524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,15420,160,1.34 [1.01-1.79],0.044381256159165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,16135,166,1.17 [0.99-1.38],0.0723712013963093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,16132,167,1.06 [0.56-2.02],0.858870441904215
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,18561,199,1.20 [0.86-1.68],0.2749219178642257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,16132,167,0.92 [0.68-1.24],0.5994070144114956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,18627,198,1.16 [0.75-1.80],0.513071718988281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,18537,199,0.99 [0.82-1.20],0.946499184471308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,15754,159,1.12 [0.98-1.29],0.0997891515233706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,18374,191,1.32 [0.99-1.75],0.0553187133539974
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,15833,164,1.15 [0.94-1.40],0.1646507021632365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,18466,193,1.42 [1.04-1.95],0.0290003023827359
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,16059,167,1.05 [0.92-1.21],0.4476072085510555
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,16091,168,1.08 [0.88-1.34],0.4582759500050014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,18454,193,1.03 [0.80-1.31],0.8406899629072375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",16057,169,0.80 [0.55-1.19],0.2743486222733371
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,18138,192,1.09 [0.82-1.44],0.5489440674755921
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,18138,192,1.19 [0.98-1.44],0.0817812210753614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,15833,164,1.03 [0.73-1.47],0.8562286215630472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,15754,159,1.15 [0.96-1.39],0.1303046788930322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,15554,161,0.93 [0.76-1.15],0.5015489507621096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,16084,168,1.10 [0.93-1.29],0.2786158558793596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,16091,168,1.10 [0.95-1.29],0.2124701498103154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,18553,197,1.10 [0.97-1.24],0.1349475162446581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,15625,163,1.14 [0.95-1.38],0.165798257115744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,15625,163,1.24 [0.88-1.75],0.2097005893131136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18163,194,0.98 [0.71-1.34],0.8924487425939753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,15585,161,0.96 [0.77-1.21],0.7433509341779836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15585,161,1.17 [0.81-1.69],0.3913367441722576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,15625,163,1.06 [0.83-1.35],0.6254546670045273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,18250,194,1.50 [1.15-1.95],0.0028563108632199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15585,161,0.89 [0.64-1.24],0.5025034690667654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,18561,199,1.07 [0.80-1.41],0.6595825636017631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,18466,193,1.15 [0.92-1.44],0.2305615747535504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,18649,198,1.12 [0.79-1.60],0.5222973585980804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,15625,163,1.06 [0.84-1.33],0.6457547337419819
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,18250,194,1.13 [0.88-1.46],0.331608169988943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,15976,163,1.14 [0.83-1.56],0.4133324517317797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,18405,192,0.89 [0.71-1.12],0.3340968710753675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,18405,192,1.01 [0.65-1.57],0.9551393316075232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16132,167,1.28 [0.73-2.24],0.3848919525848545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,16113,168,0.95 [0.56-1.61],0.8345869589093194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,16091,168,1.11 [0.89-1.38],0.3489285263614943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,15661,160,1.12 [0.97-1.31],0.1263979919025521
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,15585,161,0.89 [0.72-1.09],0.2449092000054337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,18163,194,0.99 [0.81-1.20],0.9124288324723676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,15554,161,1.25 [0.82-1.91],0.2907808540178634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,16059,167,1.08 [0.91-1.28],0.4047458379479246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,18138,192,1.12 [0.91-1.39],0.2727898935155386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,18603,198,1.11 [0.93-1.32],0.2646757495841415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15585,161,1.20 [0.92-1.57],0.1680547725552792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15585,161,0.84 [0.51-1.37],0.4750073967916468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15585,161,0.76 [0.49-1.18],0.2194327653743094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,15554,161,1.10 [0.78-1.55],0.5726928298177885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,15585,161,1.02 [0.80-1.28],0.8993894655408887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",15585,161,1.07 [0.81-1.40],0.6449436822885782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",18620,198,1.07 [0.96-1.20],0.2391503423191461
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",18163,194,1.03 [0.76-1.40],0.8261840751804055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,18138,192,1.19 [0.89-1.60],0.232936342985235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,18466,193,1.17 [0.74-1.86],0.4949347535041829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,18135,194,0.99 [0.81-1.20],0.9014891038929276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,15661,160,1.12 [0.91-1.38],0.2776854945120651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,15585,161,0.97 [0.82-1.15],0.7320570564450221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,16059,167,1.13 [0.70-1.82],0.6283307267481227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",16135,166,1.20 [0.49-2.93],0.694381321595482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,18163,194,0.96 [0.81-1.15],0.664950933719065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,15625,163,1.10 [0.97-1.24],0.1455976756041203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,16091,168,1.18 [0.89-1.56],0.245528375502626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,16084,168,1.16 [0.92-1.46],0.2105086996156023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,18553,197,1.09 [0.96-1.25],0.1871458090148676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,18649,198,1.33 [0.84-2.11],0.2218571304492147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,16091,168,1.26 [0.98-1.62],0.0663709444075036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,18021,196,1.09 [0.93-1.27],0.3073071252957614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16135,166,1.25 [0.87-1.79],0.2280815952215596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15585,161,0.79 [0.37-1.68],0.5483956673260129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15661,160,1.17 [0.77-1.77],0.4516245970622549
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18620,198,1.06 [0.66-1.68],0.8205598709732773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",18561,199,0.86 [0.51-1.46],0.5847495876251452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,15627,160,1.09 [0.66-1.79],0.7494059841008638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,18553,197,1.13 [0.95-1.33],0.1677584130334966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,18371,192,0.89 [0.65-1.22],0.4693613988992706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,15627,160,1.19 [0.89-1.58],0.239012415755603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,18233,194,1.14 [0.80-1.62],0.4616341964743244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,18138,192,0.95 [0.77-1.16],0.6044686840533242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,18138,192,1.86 [1.24-2.78],0.0024876984242551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,18553,197,1.08 [0.95-1.21],0.2373116580529546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,16084,168,1.02 [0.83-1.26],0.8277407594320243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,15701,162,1.00 [0.84-1.19],0.9839935916419374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,18132,193,1.08 [0.94-1.24],0.2752939997736067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,18561,199,0.85 [0.50-1.45],0.5576584033807248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,18405,192,1.22 [0.84-1.77],0.2946447582826634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",16113,168,0.93 [0.57-1.53],0.7798576338035036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15625,163,0.86 [0.63-1.19],0.3716916807940112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,15833,163,0.70 [0.40-1.23],0.2121957606739211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,16059,167,0.93 [0.69-1.24],0.605309137074188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,16084,168,1.07 [0.93-1.25],0.3436778651720538
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18553,197,1.08 [0.79-1.48],0.6234793540821923
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,15627,160,1.12 [0.88-1.42],0.374307684169916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,15554,161,1.14 [0.93-1.41],0.2058323209008762
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,16057,169,1.11 [0.84-1.47],0.4441669234077826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,18553,197,1.09 [0.95-1.25],0.226262376251156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,16119,165,1.02 [0.86-1.22],0.7929478513584706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,15661,160,1.20 [0.93-1.54],0.156802189074548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,15554,161,1.10 [0.80-1.51],0.5508262125663255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,16119,165,0.97 [0.81-1.17],0.7860451132775124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,18111,191,1.00 [0.90-1.12],0.9329406228019403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,15625,163,1.04 [0.84-1.28],0.7409432556618274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15585,161,0.59 [0.33-1.03],0.0635557472608326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,18553,197,0.98 [0.81-1.19],0.8741996464487658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,18561,199,1.05 [0.91-1.21],0.5079815367473497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,18138,192,1.23 [1.01-1.49],0.0411098215900696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,18792,201,0.85 [0.56-1.28],0.4268680833064187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15627,160,1.28 [0.90-1.83],0.1738586255281545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15625,163,0.93 [0.75-1.16],0.5353530941719309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,16084,168,1.21 [0.86-1.72],0.2735644705427662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,18561,199,1.02 [0.84-1.23],0.8470490596513494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,15754,159,1.12 [0.65-1.92],0.6777633194648864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,18371,192,1.02 [0.77-1.34],0.904536181369177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,18203,194,1.03 [0.74-1.42],0.8808479492329276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,15754,159,1.05 [0.53-2.08],0.8958222373890701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,16113,168,0.99 [0.64-1.53],0.9709658129503304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15627,160,1.09 [0.78-1.54],0.6052642073399975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,18233,194,1.38 [0.79-2.41],0.2509322912953892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,15625,163,1.02 [0.77-1.36],0.8799204737846176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,15661,160,1.12 [0.84-1.49],0.4538596400410976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,15118,157,0.97 [0.84-1.12],0.6770353005334813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,18534,199,0.95 [0.79-1.16],0.6405957821580879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,16083,166,1.03 [0.81-1.31],0.8120805986404753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,15896,166,1.09 [0.95-1.25],0.2338111180473678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,15833,164,1.07 [0.65-1.75],0.7974283668010395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,15625,163,1.01 [0.66-1.53],0.9748555077819728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,15585,161,0.91 [0.65-1.26],0.5627356111435966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,15585,161,1.04 [0.69-1.57],0.8397965785004771
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,18163,194,1.10 [0.83-1.46],0.5120229036911625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,15625,163,1.15 [0.82-1.62],0.425556259832623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,16091,168,1.09 [0.74-1.63],0.652753754410665
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BSG,Basigin,18750,201,1.31 [0.70-2.47],0.402310508378837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BSND,Barttin,15554,161,1.02 [0.65-1.59],0.9420215707598544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18728,202,0.78 [0.63-0.96],0.0174370365206085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18728,202,0.83 [0.63-1.10],0.1851467908746881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,18138,192,1.07 [0.91-1.27],0.4088802346211749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,16135,166,0.95 [0.46-1.95],0.8821554000085072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,15554,161,0.70 [0.55-0.90],0.0047168629976911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,16024,169,1.00 [0.68-1.47],0.9961058145551271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18620,198,1.29 [0.81-2.08],0.2855573220472804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18553,197,1.01 [0.72-1.43],0.9371055872593684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,15554,161,1.10 [0.77-1.56],0.5993071129289249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,18163,194,0.83 [0.67-1.04],0.1029575586236181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,15585,161,0.84 [0.51-1.37],0.4794402784317559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,18691,200,1.04 [0.59-1.83],0.9015718424273564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",16091,168,1.00 [0.81-1.23],0.997478224762256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,15627,160,1.13 [0.80-1.60],0.4778316517976266
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18649,198,0.84 [0.62-1.14],0.26197052533895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15754,159,1.26 [0.82-1.95],0.2967085558021314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,16091,168,1.35 [0.92-2.00],0.1265941906871432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15730,159,0.86 [0.64-1.17],0.3481332650115509
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,16135,166,0.98 [0.43-2.24],0.9647064772350464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,16100,166,1.64 [0.76-3.56],0.2092964107088606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,16135,166,0.64 [0.32-1.29],0.210977927422212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2,Complement C2,18627,198,0.88 [0.51-1.52],0.6428947649973875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,18135,194,0.98 [0.72-1.33],0.8859086279969899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,15701,162,1.30 [1.09-1.54],0.0036424567590405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C3,Complement C3,15317,157,1.17 [0.85-1.60],0.3398435142401957
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,18603,198,0.90 [0.64-1.25],0.52071734588085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C5,Complement C5,16135,166,0.86 [0.31-2.37],0.7647142745891673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,15753,163,0.99 [0.61-1.59],0.9510341160431044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,16084,168,1.23 [0.72-2.08],0.4463006389156637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,16135,166,1.14 [0.70-1.88],0.5940413592601811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,16132,167,0.85 [0.66-1.10],0.2112426167908069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,16059,167,1.05 [0.87-1.26],0.602992594538205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,18199,196,1.02 [0.82-1.27],0.8492866457011694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,18138,192,0.94 [0.60-1.49],0.8067574635668526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,18466,193,1.40 [0.95-2.06],0.0850318616493161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,18338,198,1.05 [0.93-1.18],0.4517118082055108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,18737,201,1.11 [0.78-1.57],0.5622968156941649
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,18503,199,1.07 [0.90-1.29],0.4448781310688915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,18766,200,1.12 [0.92-1.38],0.2638223089087626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,18792,201,1.18 [0.70-1.97],0.5380424501500773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",18233,194,0.94 [0.81-1.09],0.4146003519599401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,18503,199,1.20 [0.98-1.47],0.0806838387984144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,15833,164,0.89 [0.56-1.41],0.6057007781699322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,15627,160,1.04 [0.58-1.87],0.8909639801400095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,18737,201,0.83 [0.63-1.09],0.1777379565870324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,15701,162,1.13 [0.92-1.40],0.2483343782666764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15625,163,0.75 [0.45-1.26],0.2826737723891742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15585,161,1.24 [1.01-1.51],0.0357145575565868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15625,163,1.07 [0.84-1.36],0.5794675354090775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,16091,168,1.06 [0.89-1.26],0.5228697017848086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,15727,159,1.13 [0.97-1.31],0.1103717740845988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,15701,162,1.06 [0.73-1.53],0.7626161001398643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,18466,193,1.25 [0.93-1.67],0.1437187713840812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,18163,194,1.04 [0.66-1.64],0.8531393162317662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,18377,192,1.00 [0.82-1.20],0.969538095742446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,16084,168,1.30 [0.95-1.79],0.105669764434163
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18682,200,1.11 [0.98-1.26],0.0914364649596211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15661,160,1.16 [0.95-1.42],0.1378189821418438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,15585,161,0.82 [0.52-1.29],0.3980297358239016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,18138,192,0.99 [0.74-1.33],0.960155538353508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15701,162,1.23 [0.96-1.58],0.1051761764785733
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,16091,168,1.09 [0.95-1.25],0.2356061722589889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18499,200,0.73 [0.39-1.37],0.3269603475084509
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,18443,193,1.12 [0.90-1.38],0.3139321976094002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,16057,169,1.20 [0.83-1.73],0.3343578708706415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,16084,168,1.04 [0.91-1.19],0.5730934284872214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,18163,194,1.03 [0.81-1.32],0.7959060678227371
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,15701,162,1.23 [0.87-1.73],0.2379691219061847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,18163,194,0.95 [0.79-1.15],0.6235112808348218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,18163,194,0.99 [0.83-1.19],0.9281958829015023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,18553,197,1.05 [0.87-1.26],0.6393420571414316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,18792,201,1.05 [0.91-1.21],0.5270608745003482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,15833,164,1.09 [1.01-1.18],0.0331023722970113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,16084,168,1.13 [0.95-1.35],0.1733764767624317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,18687,200,1.10 [0.91-1.34],0.3361690090491601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,15627,160,1.01 [0.79-1.29],0.9566832925460568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,15585,161,0.75 [0.51-1.11],0.1482772137259301
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAT,Catalase,15894,161,1.16 [0.89-1.53],0.2742874218100822
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,18543,201,1.00 [0.85-1.17],0.9520422551968352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,15625,163,0.97 [0.82-1.15],0.7082485363958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,18737,201,0.78 [0.52-1.15],0.2115531713569734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,15661,160,1.00 [0.74-1.36],0.9812881338403936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,15585,161,0.84 [0.54-1.30],0.4407434500089217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18405,192,1.08 [0.91-1.28],0.3770116565706261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,16084,168,0.90 [0.67-1.23],0.5139472672123997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,16057,169,1.18 [0.88-1.58],0.2650794396720046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,15701,162,0.76 [0.45-1.26],0.2875013445061629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,16091,168,1.01 [0.83-1.22],0.9440398941069512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,18563,201,1.38 [0.98-1.94],0.0676714591408002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15661,160,1.36 [1.08-1.71],0.0085991936043282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,18783,201,1.07 [0.76-1.49],0.7089756108914194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,18755,200,0.99 [0.83-1.19],0.9543238318785646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18536,198,1.05 [0.77-1.44],0.7594250958136249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,18792,201,1.00 [0.75-1.34],0.9949974929994438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,18792,201,1.12 [0.87-1.45],0.3718734015938805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,18501,197,0.93 [0.81-1.06],0.2813004162481268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,18332,193,0.90 [0.74-1.09],0.2840756343600964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,18728,202,0.84 [0.73-0.96],0.0122749974155357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,18371,192,1.07 [0.84-1.36],0.5982721270744731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,18783,201,0.94 [0.80-1.09],0.4000268863561114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,18620,198,0.82 [0.58-1.16],0.259259025134663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,18341,196,0.94 [0.74-1.21],0.6527516329212075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,18620,198,0.92 [0.67-1.25],0.585930991460865
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,18598,197,0.99 [0.85-1.15],0.8639809843521242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,18783,201,1.04 [0.81-1.35],0.7461848216937474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,18553,197,0.95 [0.82-1.09],0.44934910629221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,18563,201,1.01 [0.83-1.25],0.8971867771221574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,18490,197,1.01 [0.81-1.25],0.9296689050173542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18553,197,1.20 [0.99-1.46],0.0653927738493235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,18562,198,1.18 [1.00-1.39],0.0455872205192414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,18649,198,0.91 [0.81-1.03],0.1499255202981317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,18553,197,1.02 [0.81-1.27],0.8885285895067259
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,18710,200,1.11 [0.90-1.37],0.3116765885437169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,18439,192,0.99 [0.83-1.19],0.924425197506238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,18545,197,1.07 [0.85-1.34],0.5713437213917567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,18754,200,1.22 [0.83-1.78],0.3054907364436792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,18737,201,1.51 [1.11-2.05],0.0092576575392411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,18561,199,1.30 [0.94-1.81],0.1158546721786386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,15833,164,0.99 [0.66-1.50],0.9611520887008728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,15627,160,1.10 [0.95-1.26],0.1985392364788696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,18405,192,1.16 [0.89-1.51],0.2853554735867415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,18138,192,1.11 [0.84-1.47],0.4457268403819765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,16059,167,0.88 [0.64-1.22],0.4550954726790035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,18561,199,1.17 [0.80-1.71],0.4252011741690329
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18222,195,1.04 [0.76-1.43],0.7937648148478115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18783,201,1.07 [0.82-1.40],0.6023391869060806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18649,198,0.96 [0.71-1.29],0.7769180869003578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,18561,199,1.13 [0.73-1.75],0.5892101164700425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,15701,162,0.89 [0.58-1.35],0.5722954419468391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,18528,198,1.03 [0.93-1.13],0.5656599627807783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18603,198,1.72 [1.01-2.93],0.0453382328847278
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,15585,161,0.91 [0.60-1.37],0.649687251189387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18553,197,1.23 [0.76-1.98],0.3991141066025749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,18486,196,1.30 [0.92-1.84],0.1408672630255406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,18123,189,1.43 [1.03-2.00],0.0346728950186734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,18609,199,0.76 [0.54-1.06],0.1025961240008467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18783,201,0.88 [0.65-1.20],0.417206049006281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,15627,160,1.40 [0.99-2.00],0.0605962587376247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,18783,201,1.15 [0.73-1.81],0.5390490880034319
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,16119,165,1.33 [0.92-1.92],0.1305532792570999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18603,198,1.13 [0.83-1.54],0.4450477880787256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18405,192,0.95 [0.64-1.41],0.7880180591612973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,18529,197,1.43 [0.99-2.06],0.056643008905875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18138,192,1.03 [0.73-1.46],0.8734805125394659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,18563,201,1.07 [0.88-1.30],0.5197166820758721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15754,159,1.71 [1.05-2.79],0.0324360996584154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18728,202,1.26 [0.88-1.81],0.2038406912200222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18681,199,1.09 [0.80-1.49],0.5917766665390373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18737,201,1.23 [0.98-1.55],0.0736825149357056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,18561,199,1.41 [1.01-1.97],0.0457841194020879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,18466,193,1.81 [1.23-2.67],0.0027799794221301
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,18603,198,1.01 [0.87-1.18],0.8809269308145657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,18668,202,1.14 [0.68-1.91],0.6156261991641868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,15627,160,1.18 [0.85-1.64],0.3236481337359466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18466,193,1.06 [0.71-1.59],0.760701657517798
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,15625,163,1.12 [0.74-1.70],0.5818964938672557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,15833,164,1.23 [0.89-1.70],0.2084898272156597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,15627,160,1.14 [1.00-1.31],0.0546912749512044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,18521,197,0.96 [0.62-1.49],0.867393529772214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,18540,197,1.23 [0.96-1.57],0.1062236397249725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,18783,201,1.05 [0.90-1.22],0.5669304133317039
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18481,197,1.05 [0.67-1.64],0.8275991852906945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18598,197,1.23 [0.80-1.88],0.3486997766581527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18710,200,1.22 [0.84-1.76],0.3017651305460928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,17933,188,1.23 [0.76-2.00],0.3955124369743243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,18495,197,1.77 [0.86-3.63],0.1225805423946963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,17915,190,1.77 [1.06-2.97],0.0304650375034808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,16066,165,1.11 [0.81-1.52],0.5252650890378394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18750,201,1.00 [0.78-1.27],0.9809983624920438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,18371,192,0.97 [0.75-1.25],0.8010424602951425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,18470,200,1.02 [0.89-1.18],0.7570623576716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,15599,159,1.16 [0.82-1.63],0.4072657461901146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18553,197,1.00 [0.74-1.33],0.9765303092979716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15754,159,1.00 [0.68-1.46],0.9946849207978724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18728,202,1.15 [0.79-1.66],0.4685197654998763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18783,201,1.13 [0.85-1.51],0.4093154043756059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16113,168,0.75 [0.47-1.20],0.226132190716437
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,15833,164,1.00 [0.69-1.46],0.9854568787732574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18553,197,1.08 [0.74-1.58],0.6982388685888381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,18553,197,1.14 [0.77-1.70],0.505576205008977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,16059,167,1.15 [0.69-1.92],0.5836252906301158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18728,202,1.09 [0.85-1.38],0.4975178730028683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,17886,191,1.05 [0.69-1.60],0.825537408586909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,18561,199,1.58 [0.84-2.97],0.1583191190758224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,18561,199,1.53 [0.92-2.55],0.1017587552556225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,16092,168,1.07 [0.79-1.45],0.647538930359105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,16084,168,1.22 [0.67-2.24],0.5128368926614019
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,15554,161,1.22 [1.00-1.49],0.0462018772975897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,15554,161,1.27 [0.91-1.76],0.1560961226749006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,16021,167,1.18 [0.95-1.45],0.1281107322691332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,18138,192,1.07 [0.87-1.32],0.5009658742740053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,18603,198,1.06 [0.91-1.23],0.4410869744963701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,16059,167,1.07 [0.93-1.24],0.3326530483373326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18405,192,0.85 [0.67-1.09],0.2000502395806703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,17956,188,1.17 [0.86-1.59],0.3249281815940644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,18700,202,0.94 [0.78-1.12],0.4679820283712019
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,18563,201,1.03 [0.86-1.23],0.768250645042337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,18563,201,0.73 [0.51-1.06],0.0953490662326214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,15833,164,0.62 [0.34-1.11],0.108847972097951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,16084,168,1.08 [0.63-1.86],0.7721949811811508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18728,202,1.64 [1.18-2.29],0.0035143679032902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,15625,163,1.14 [0.84-1.55],0.3861421811211576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,18792,201,1.11 [0.73-1.67],0.627998612370424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,18563,201,0.82 [0.58-1.14],0.2318623245977496
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,18163,194,1.22 [0.92-1.62],0.160730215244704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,18466,193,0.90 [0.74-1.10],0.3019058138352216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,18563,201,1.04 [0.75-1.44],0.8263521684564263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,15554,161,1.39 [0.91-2.10],0.1235882272694229
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,16091,168,1.17 [0.93-1.47],0.1705171845997625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,15625,163,1.03 [0.78-1.37],0.8176009257554735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,18466,193,1.07 [0.95-1.20],0.2734964864508818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18466,193,1.12 [0.97-1.29],0.1156454620470909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,18466,193,1.31 [0.92-1.86],0.1295903223815343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18559,197,0.89 [0.54-1.47],0.6534216915643343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,18731,200,1.28 [0.96-1.71],0.0960830005667966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18576,198,0.94 [0.50-1.75],0.8415663355219362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16059,167,0.98 [0.82-1.18],0.8320170681955323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15833,164,1.07 [0.88-1.31],0.4947113863522743
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16059,167,1.59 [1.13-2.22],0.0076038986754996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15833,164,1.44 [1.08-1.91],0.0119247163638207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18553,197,0.98 [0.84-1.13],0.7441751113480628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,18138,192,1.19 [0.93-1.52],0.1616185159854374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17901,190,1.10 [0.89-1.37],0.3681428800583257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16119,165,0.86 [0.58-1.28],0.4580337264055544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18233,194,1.24 [0.97-1.60],0.0915323069342242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,15627,160,1.31 [0.93-1.82],0.1176853689364661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,18233,194,1.22 [0.88-1.68],0.226879075948917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,16119,165,1.06 [0.84-1.34],0.6297037647132755
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,18761,201,1.15 [0.93-1.41],0.1987123089746227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15754,159,0.98 [0.57-1.69],0.9514506717098816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,15627,160,1.31 [0.84-2.03],0.2299404322321659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,15625,163,0.93 [0.70-1.22],0.5866389551434299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,15833,164,1.18 [0.91-1.53],0.216457608267991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,15833,164,0.93 [0.74-1.17],0.5349074242102179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,15585,161,1.07 [0.78-1.46],0.6721180337883996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,15554,161,1.13 [0.81-1.58],0.4732260388238856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,18250,194,1.05 [0.87-1.27],0.6070416770791696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,15661,160,1.12 [0.92-1.36],0.2498107542226381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,18138,192,1.15 [0.97-1.35],0.1055652111630745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,15833,164,1.15 [0.91-1.47],0.2436265894780657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,15554,161,1.44 [1.03-2.03],0.0337134770025001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,18090,191,1.05 [0.87-1.27],0.5979131217036107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,18138,192,1.06 [0.87-1.29],0.5629047398387087
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,18163,194,1.02 [0.83-1.26],0.8406757109555347
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,18606,200,0.96 [0.83-1.12],0.6106324563361034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,18466,193,1.13 [0.90-1.40],0.2911723712799108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,18466,193,1.02 [0.85-1.22],0.8504817883032096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,18163,194,1.13 [0.94-1.36],0.182836612838969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,16059,167,1.11 [0.92-1.34],0.2918499856722098
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,15861,162,0.68 [0.43-1.09],0.1102817510426829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,18138,192,1.05 [0.80-1.39],0.7052822123412181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,16135,166,1.44 [0.74-2.79],0.2790652040122169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,15225,154,0.71 [0.36-1.40],0.3225119922583581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,16019,164,1.10 [0.83-1.44],0.5093670964219006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,16100,165,1.05 [0.85-1.29],0.6742223372001763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,15931,164,0.77 [0.54-1.10],0.1508878592228321
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,16135,166,0.64 [0.30-1.38],0.2516272059023429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFP,Properdin,16135,166,0.83 [0.41-1.69],0.6070524169135774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18561,199,1.03 [0.84-1.26],0.7758618604605911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,16132,167,0.86 [0.57-1.27],0.442412071896149
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,15701,162,0.69 [0.43-1.09],0.1098651512625535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,18563,201,1.33 [1.00-1.78],0.0503578633821712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,18138,192,1.04 [0.84-1.30],0.7045820546261591
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15754,159,1.17 [0.84-1.65],0.3521451024347171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16084,168,1.21 [0.86-1.71],0.2763967930398028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,16057,169,0.82 [0.46-1.44],0.4837396827759472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,18233,194,1.36 [0.93-2.00],0.1101260173290766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,16119,165,0.93 [0.78-1.12],0.4647071151172495
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,18678,202,0.98 [0.73-1.33],0.919640302238108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,18184,195,1.00 [0.85-1.17],0.9953246331539588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,18649,200,1.07 [0.97-1.17],0.1729218486866233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,18621,197,0.96 [0.63-1.48],0.8688069895149274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,15701,162,1.10 [0.86-1.41],0.430793830223206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,18405,192,1.07 [0.91-1.26],0.3874152191126481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,16113,168,1.08 [0.83-1.40],0.5667359505118984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,15625,163,1.15 [0.96-1.37],0.1220007563800398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,18598,197,1.09 [0.73-1.62],0.6849356520704661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,18563,201,0.87 [0.66-1.15],0.3258077761751697
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,15701,162,1.22 [0.84-1.75],0.2932024186087454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,18603,198,1.10 [0.90-1.35],0.3575841831032852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,16119,165,1.25 [0.95-1.66],0.114446495245459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,15833,164,1.10 [0.80-1.52],0.5430792491976688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,16059,167,1.06 [0.90-1.23],0.4863364329048992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,15701,162,1.23 [0.92-1.65],0.1610652000277831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18692,201,1.56 [1.06-2.31],0.025561453966399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,16119,165,1.14 [0.87-1.48],0.3339552343312263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18476,197,1.04 [0.85-1.27],0.7348318425901958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,15554,161,1.09 [0.91-1.32],0.3447455862823364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,18533,200,1.00 [0.83-1.20],0.9977236369756486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,18405,192,0.99 [0.70-1.42],0.9713301363866036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,18533,199,1.35 [1.03-1.75],0.0283765793100111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15627,160,2.72 [1.75-4.22],8.116401908200815e-06
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,18561,199,1.34 [0.91-1.98],0.1390754575553611
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,18233,194,1.33 [0.91-1.94],0.1360791972025419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,18728,202,1.01 [0.89-1.15],0.8578595104434188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,15701,162,1.06 [0.81-1.39],0.6701867947693723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,15773,162,0.94 [0.46-1.93],0.8751165814018805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,18553,197,1.20 [0.84-1.72],0.3243341153087225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18553,197,1.32 [1.01-1.71],0.0389512852318633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,18553,197,1.08 [0.87-1.32],0.490790093080737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,18553,197,1.00 [0.68-1.46],0.991578954466125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,16097,165,0.87 [0.64-1.18],0.3774474226477093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,18503,201,1.40 [0.93-2.10],0.110160410986078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,18138,192,1.16 [0.89-1.53],0.2767992587679129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,18783,201,1.27 [0.99-1.64],0.0594561866558004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,15701,162,1.47 [1.12-1.93],0.0059626085004311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,15701,162,1.12 [0.71-1.77],0.634067346562588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,15554,161,0.87 [0.61-1.24],0.435285733634535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,18553,197,1.08 [0.97-1.21],0.1687792084101912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,18737,201,2.13 [1.22-3.71],0.0076165470557394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,15701,162,1.15 [0.76-1.75],0.5078247210747695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18377,192,0.99 [0.87-1.13],0.913174351517975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,18523,199,1.11 [0.94-1.32],0.2207088881299902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,18135,194,1.21 [0.92-1.58],0.1758893091530328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,18163,194,1.16 [0.93-1.45],0.1914706934417597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,18783,201,1.16 [0.86-1.58],0.3282285841490376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,16084,168,1.40 [0.88-2.22],0.1582505385935381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,18233,194,0.97 [0.73-1.29],0.830617418366204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,16135,166,1.13 [0.71-1.78],0.6128767076430659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,18529,201,1.14 [0.86-1.51],0.3516491788341104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,16113,168,1.06 [0.91-1.25],0.4451934653157422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,16057,169,1.05 [0.88-1.25],0.5894240939739703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,18649,198,1.08 [0.81-1.43],0.6061838401165001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,15625,163,1.19 [0.95-1.50],0.1297586772427433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15633,160,1.11 [0.91-1.34],0.3020255825187108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,18233,194,1.03 [0.84-1.26],0.7780857852831027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,18466,193,1.07 [0.90-1.27],0.4414569612221869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNST,Consortin,18563,201,1.06 [0.95-1.20],0.2878649841868336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,15625,163,0.95 [0.61-1.47],0.8144377654839847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,18792,201,1.12 [0.70-1.79],0.6427504076000734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,18737,201,1.17 [0.89-1.55],0.2625198456956683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,18561,199,0.91 [0.58-1.44],0.6969414186389085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,18561,199,1.17 [0.69-2.00],0.5600730739154931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,18612,201,1.39 [1.00-1.95],0.0513964447062482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,18553,197,1.34 [1.00-1.79],0.0478848526120708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,15701,162,1.09 [0.96-1.23],0.1805972931655309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,16113,168,1.11 [0.80-1.53],0.5337936792494342
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,16119,165,1.38 [0.78-2.43],0.2646417685727393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,18636,200,1.15 [0.67-1.98],0.6120082367020193
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,18792,201,1.58 [0.94-2.66],0.0827526501813503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,16059,167,0.90 [0.70-1.16],0.413785519967088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,15701,162,0.85 [0.70-1.04],0.113828644910339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,15661,160,1.16 [0.96-1.41],0.1155749790252703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,16119,165,0.95 [0.50-1.79],0.8630386258442122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,18563,201,1.06 [0.76-1.47],0.7329582329942739
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,15804,164,1.19 [0.89-1.60],0.234594451658629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,15754,159,1.24 [0.85-1.80],0.2722927670816741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18792,201,1.37 [0.96-1.93],0.0795454791450553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,18553,197,1.15 [0.88-1.51],0.2983187427781413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15833,164,1.10 [0.81-1.51],0.5285897876723318
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18529,197,1.32 [0.82-2.13],0.2521151614863252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,15661,160,1.23 [0.96-1.57],0.1017864524523631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,16057,169,1.14 [0.81-1.60],0.45197215404736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,18386,195,1.07 [0.73-1.58],0.7187709073243143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,18035,193,0.97 [0.83-1.13],0.6615764387586287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',15585,161,1.31 [0.97-1.77],0.0803185709143099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,18163,194,1.20 [0.96-1.50],0.1175996609884688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15661,160,1.12 [0.80-1.57],0.5056716840291375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,18200,200,1.05 [0.91-1.20],0.4979409002500846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,15625,163,1.07 [0.72-1.59],0.7502009260131188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18466,193,1.08 [0.90-1.29],0.4110784182134631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,16113,168,0.90 [0.57-1.42],0.6428262128616598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,18792,201,1.17 [0.97-1.42],0.0995041635228706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,18675,202,1.08 [0.90-1.30],0.4102166930316333
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,15453,158,0.99 [0.69-1.43],0.9737021498109456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,18792,201,1.27 [1.05-1.54],0.015024315580468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,16110,166,0.80 [0.41-1.55],0.5112517347891912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,18575,199,1.08 [0.78-1.49],0.6520422762302474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,15554,161,1.07 [0.67-1.68],0.7851411521010838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,18640,200,0.70 [0.48-1.02],0.0623026585184155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15627,160,1.08 [0.62-1.90],0.7832049998180244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,18728,202,1.00 [0.82-1.20],0.9598986744946918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,16092,165,0.75 [0.50-1.13],0.1719839737881903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,15585,161,1.13 [0.80-1.61],0.4867590047612136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,18699,198,1.08 [0.80-1.47],0.612765140058867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,18603,198,1.03 [0.86-1.24],0.7416669302027628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,16113,168,1.00 [0.55-1.80],0.9996637341945118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,16076,167,0.84 [0.55-1.29],0.4331887805892279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18649,198,1.00 [0.76-1.32],0.9879938986309031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,18138,192,1.12 [0.97-1.29],0.1261459720368684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,18377,192,1.05 [0.89-1.25],0.54426851657598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,15554,161,1.04 [0.79-1.36],0.8047193244369517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,15554,161,1.33 [0.77-2.31],0.3088140329625816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,18314,194,1.05 [0.77-1.44],0.7654803208470762
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,15754,159,0.62 [0.40-0.94],0.0262516154565152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,18598,197,1.13 [0.89-1.43],0.3313225740843016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,18112,192,0.92 [0.79-1.07],0.2634975119803836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,18529,197,1.04 [0.65-1.66],0.8741484654481713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,18233,194,1.04 [0.85-1.28],0.696511699830938
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,18620,198,1.67 [0.90-3.10],0.1036690210207528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,18405,192,1.11 [0.79-1.54],0.5557000675804933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,18737,201,0.86 [0.69-1.07],0.1821520001124866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,15977,166,1.53 [0.88-2.67],0.1318192075977487
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,18564,197,1.08 [0.96-1.22],0.222022787981118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,18620,198,0.99 [0.60-1.65],0.9766601186642212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,18035,193,1.03 [0.85-1.24],0.7653170823358084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,18792,201,1.40 [0.93-2.12],0.1069530756768026
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18405,192,0.94 [0.72-1.21],0.6173344773667787
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,15701,162,1.16 [0.89-1.52],0.2803555891706083
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,18233,194,0.95 [0.84-1.09],0.4769937923793147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,16113,168,1.15 [0.92-1.44],0.2289356279109112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,16084,168,0.91 [0.72-1.15],0.4143942985559893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,16084,168,1.18 [1.01-1.37],0.0334790054589133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,15625,163,1.12 [0.92-1.35],0.2643238507423904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,15661,160,1.08 [0.91-1.28],0.3800395414465516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,15585,161,1.07 [0.95-1.20],0.258319735605062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18620,198,1.50 [0.93-2.39],0.093205377387018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16132,167,1.05 [0.72-1.53],0.7971541189417228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,15585,161,0.91 [0.59-1.39],0.651471300730851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18405,192,1.21 [1.00-1.48],0.0509240228494664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,15627,160,0.90 [0.63-1.29],0.5754020435788647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,18250,194,0.90 [0.68-1.17],0.4205416607030111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,15627,160,1.23 [0.73-2.05],0.4359164396105865
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,16132,167,0.95 [0.57-1.58],0.8365609616029624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,15627,160,1.22 [0.98-1.52],0.0746245590673893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,16091,168,1.02 [0.73-1.41],0.9272688299858828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,16119,165,1.22 [0.78-1.92],0.3854277954464994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,15625,163,0.95 [0.69-1.30],0.7360412877326379
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,15585,161,1.05 [0.90-1.22],0.5225653920808365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,13994,145,1.01 [0.86-1.19],0.9008108796732224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,18614,198,1.37 [0.88-2.13],0.1574261809291175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,18172,189,1.07 [0.84-1.35],0.5850202338138978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,18084,195,1.37 [1.05-1.77],0.0188509264802947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,18562,198,1.02 [0.89-1.16],0.7830039723071319
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,18308,196,1.10 [0.82-1.47],0.5193918810569478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,15805,163,0.93 [0.68-1.27],0.6679971604626016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,15911,167,0.73 [0.42-1.25],0.2499497628931269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,18233,194,1.08 [0.93-1.25],0.3289897932153541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,16119,165,1.84 [1.11-3.05],0.0185076102494983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,16119,165,1.09 [0.69-1.71],0.7064108855375522
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,15625,163,1.24 [0.86-1.80],0.2475196572600652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,18561,199,1.05 [0.84-1.30],0.6857854872072913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,18529,197,1.23 [1.01-1.49],0.0353509449339477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,16084,168,1.07 [0.87-1.33],0.511308603603793
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,18568,200,1.03 [0.81-1.31],0.7967686191770031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,18495,197,0.99 [0.75-1.31],0.9289664872836304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,17371,186,1.02 [0.74-1.42],0.8930501835117883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,15754,159,0.92 [0.69-1.24],0.5881322930181351
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,18603,198,1.10 [0.80-1.51],0.5730542749530037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,18170,193,0.95 [0.80-1.13],0.5814338000200192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18563,201,0.94 [0.56-1.58],0.8105753827354989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,18783,201,0.81 [0.54-1.23],0.3271587546340078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,14650,157,1.42 [0.74-2.70],0.291793227897222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18664,197,1.00 [0.73-1.37],0.9934626649107547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,18591,198,1.06 [0.71-1.57],0.7866724828538584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,15701,162,1.20 [0.85-1.68],0.3055895943561695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15968,167,1.20 [0.99-1.45],0.0634143607609209
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,18405,192,1.26 [0.85-1.85],0.2448762060915233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,18553,197,1.17 [0.90-1.52],0.2281499393698616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,18510,198,0.91 [0.79-1.05],0.1818919208552902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,18620,198,0.94 [0.77-1.16],0.5803581500076049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,18728,202,0.93 [0.79-1.10],0.4108642549919037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,18250,194,0.78 [0.56-1.08],0.1311342867789123
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18728,202,0.95 [0.76-1.20],0.6779001189302537
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,18250,194,1.15 [0.94-1.40],0.185055307174955
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,18761,201,0.93 [0.54-1.61],0.7925122100920994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,18783,201,0.86 [0.64-1.18],0.3530048556855406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,18540,197,0.93 [0.82-1.07],0.3128073634701807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,18501,201,0.91 [0.81-1.01],0.0807986722040661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,18783,201,0.95 [0.80-1.12],0.5417478872315278
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,18452,196,0.86 [0.71-1.06],0.1535039078107517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18620,198,0.90 [0.73-1.11],0.3432913100669392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,15554,161,0.97 [0.78-1.21],0.7989322334137527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15892,164,1.33 [1.03-1.73],0.0311769384282817
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15585,161,0.99 [0.82-1.18],0.8698836781737908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,15554,161,1.12 [0.93-1.35],0.2162769561553518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,16119,165,1.15 [0.63-2.09],0.642272384742657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,15754,159,1.13 [0.94-1.35],0.2036316136175275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,18737,201,1.08 [0.96-1.21],0.1993586615695681
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,18620,198,1.06 [0.82-1.39],0.6467714418643626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,15627,160,1.18 [0.94-1.48],0.1437625402632462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,15627,160,1.13 [0.88-1.44],0.3424308128148678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18553,197,1.07 [0.96-1.20],0.1927871241275539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",18377,192,1.03 [0.86-1.23],0.759571716573592
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,16111,167,0.98 [0.86-1.11],0.7388950308854529
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,18473,198,1.12 [0.96-1.32],0.1534492302391177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,15627,160,1.28 [0.96-1.70],0.0871691887324441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,18620,198,1.08 [0.94-1.24],0.2647160756579721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18603,198,0.83 [0.58-1.18],0.2924121733527153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,15701,162,1.50 [0.96-2.34],0.0766140815152694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,15554,161,1.08 [0.86-1.35],0.5303777754833863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,15554,161,1.15 [0.71-1.85],0.569446470559591
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCN,Decorin,18233,194,1.66 [0.96-2.85],0.0686951912794212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,15754,159,1.14 [0.97-1.34],0.125207762870447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,18737,201,1.07 [0.88-1.30],0.5213280297142253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,18466,193,1.08 [0.94-1.23],0.2844497566535541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,18163,194,1.05 [0.89-1.25],0.5626310994766164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18563,201,1.08 [0.72-1.62],0.7065304009198994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,15625,163,0.95 [0.77-1.17],0.6121307888332592
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,15554,161,0.96 [0.79-1.17],0.7064375206584248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,18603,198,0.83 [0.65-1.05],0.119247571633268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,15585,161,1.05 [0.72-1.55],0.7893289744712108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18466,193,1.17 [0.88-1.55],0.2878054982224912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,18543,201,1.01 [0.77-1.33],0.92797604685109
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,16091,168,1.11 [0.89-1.39],0.3710913939981181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,15754,159,1.03 [0.84-1.26],0.770125424066532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18728,202,0.98 [0.57-1.69],0.9416376729516638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,16119,165,0.95 [0.66-1.37],0.7888098787870093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,16059,167,1.06 [0.79-1.42],0.6897286951838524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,15701,162,1.23 [0.84-1.79],0.2825856787196119
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,15627,160,1.07 [0.58-1.98],0.833134055667589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,15627,160,1.14 [0.90-1.46],0.2765007111944562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,15701,162,1.33 [0.95-1.85],0.0952943657671667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,18138,192,1.02 [0.82-1.28],0.8376099426872323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18553,197,1.03 [0.90-1.18],0.6471362934130456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,18215,195,0.94 [0.74-1.20],0.6328062209318526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,15519,159,0.97 [0.67-1.40],0.8725602134072892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,15625,163,1.04 [0.79-1.36],0.7798287807471704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,15625,163,1.04 [0.85-1.28],0.6914820707177232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,15625,163,1.00 [0.76-1.31],0.9837541706689544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,18270,192,1.05 [0.96-1.15],0.2656082748766641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,15585,161,0.97 [0.71-1.33],0.8538159063376243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,15627,160,1.32 [1.06-1.64],0.014117275711826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,18783,201,1.13 [0.94-1.35],0.207143824900142
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,15625,163,0.81 [0.54-1.21],0.3067828590017045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,15627,160,1.01 [0.76-1.34],0.9568160649886912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,18250,194,1.06 [0.74-1.51],0.7456894567223324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,15585,161,0.98 [0.70-1.36],0.8907056707098586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,16057,169,1.03 [0.72-1.49],0.8711967421000737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,16084,168,1.27 [0.96-1.67],0.0927055129131664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",18503,201,1.04 [0.93-1.17],0.4558307013996358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,15701,162,1.01 [0.70-1.45],0.977061838813837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,15754,159,0.79 [0.46-1.37],0.4046839918939846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,18728,202,1.02 [0.83-1.26],0.8566986893703944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,18792,201,1.48 [0.97-2.26],0.0705910815529267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,18372,192,1.22 [0.94-1.60],0.141010491294905
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,18466,193,0.96 [0.83-1.11],0.576686403415843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,16084,168,1.12 [0.92-1.37],0.2447918393487146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,16091,168,0.84 [0.59-1.20],0.3328099217441101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,18792,201,0.94 [0.76-1.17],0.5949335630678051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18603,198,1.29 [0.85-1.97],0.2303698474663449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,15661,160,0.93 [0.76-1.13],0.456794809451579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,15661,160,1.39 [1.08-1.81],0.0116967226217599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,15661,160,0.93 [0.71-1.23],0.6304456393111464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,15554,161,1.09 [0.79-1.51],0.6137601772317951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,18725,201,1.11 [0.95-1.29],0.192341811442876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,16084,168,1.12 [0.91-1.37],0.2743006367917191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,18466,193,1.05 [0.90-1.22],0.5313307251563069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,16059,167,1.10 [0.88-1.38],0.4200618515717894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,15754,159,1.15 [0.87-1.52],0.3314561303767971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,15612,159,1.15 [0.96-1.38],0.1360825187455433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,18233,194,0.92 [0.72-1.18],0.5193200519381356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,16084,168,1.14 [0.80-1.63],0.4785712618819423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,15661,160,1.16 [0.97-1.39],0.0957197658145421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,16059,167,1.08 [0.89-1.31],0.4121826288659275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,18500,197,0.96 [0.59-1.57],0.8805448375634797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,15625,163,1.08 [0.92-1.28],0.3351863946087187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,16059,167,1.10 [0.96-1.26],0.1566575167079242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,16091,168,1.04 [0.80-1.37],0.7548271179048436
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18405,192,1.07 [0.87-1.32],0.5131110768749664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,16084,168,1.05 [0.81-1.37],0.7031521876307782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18586,198,1.16 [0.91-1.49],0.2229125485819253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,15701,162,1.14 [0.78-1.65],0.5042751591473986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,15625,163,1.06 [0.94-1.19],0.342166539918059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,16084,168,1.08 [0.97-1.21],0.1612528370562763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,18563,201,1.03 [0.93-1.14],0.5204554681958871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,18377,192,1.29 [0.97-1.71],0.077741254794481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18466,193,1.18 [0.77-1.81],0.4360638679562856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,18553,197,0.85 [0.59-1.22],0.3715431214023834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,18240,196,0.72 [0.45-1.16],0.1785878753669448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,18466,193,0.99 [0.68-1.44],0.9380269944366036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,18419,196,1.11 [0.91-1.37],0.2978508839398453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,18792,201,1.40 [0.84-2.35],0.1945945290707706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18684,199,1.20 [0.99-1.46],0.0580662763945399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,18405,192,1.23 [0.91-1.66],0.180028933236339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,18466,193,1.14 [0.91-1.42],0.2508203506483612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18330,197,1.36 [0.94-1.96],0.0998938956305516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,16091,168,1.09 [0.72-1.64],0.698683619115368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,18561,199,1.57 [0.99-2.47],0.0535489072205294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,18675,198,1.80 [1.26-2.56],0.0010906003726269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,18401,193,1.43 [1.11-1.83],0.0048528196061365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,15754,159,1.17 [0.99-1.40],0.0729866372531965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,16019,169,1.22 [0.89-1.68],0.223122579717183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,15701,162,1.01 [0.79-1.30],0.9261147074187056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18466,193,1.03 [0.60-1.78],0.90960646108239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,16113,168,1.07 [0.86-1.33],0.5307668577125272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,18233,194,1.07 [0.91-1.26],0.4224330502797636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,16057,169,0.80 [0.56-1.15],0.2373802392669246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,15701,162,1.00 [0.79-1.26],0.985963875595542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,18163,194,0.92 [0.78-1.08],0.2877731915513649
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",16059,167,1.02 [0.89-1.18],0.7457396709851623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,16084,168,1.21 [0.88-1.66],0.2414286381936653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,16057,169,1.04 [0.77-1.42],0.7785664097307454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,15701,162,1.06 [0.88-1.28],0.5395516756097195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,16057,169,1.13 [0.81-1.57],0.4718928228851239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18405,192,1.04 [0.91-1.19],0.574488242180855
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18714,201,1.31 [0.87-1.99],0.1955500175941117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,18163,194,0.79 [0.55-1.13],0.195654895374279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",16113,168,0.98 [0.80-1.21],0.8797518552548008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15661,160,1.06 [0.90-1.24],0.4827596939949108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,15585,161,0.98 [0.76-1.26],0.8819950494737273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,15713,164,1.13 [0.74-1.70],0.5742856896145881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,15625,163,0.96 [0.71-1.30],0.7978877436436971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18737,201,1.27 [0.92-1.76],0.1438507191626508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18553,197,1.04 [0.90-1.19],0.6275486330542985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,16057,169,1.16 [0.91-1.46],0.2274670690884447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15585,161,1.06 [0.72-1.56],0.7611004147663066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,16091,168,0.94 [0.75-1.18],0.5975781175504653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18233,194,1.11 [0.77-1.61],0.5721538376686026
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,15661,160,1.04 [0.61-1.77],0.8769218561996567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,15627,160,1.31 [1.01-1.72],0.0455182359409507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,16113,168,1.10 [0.93-1.28],0.2624678515526094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,16059,167,1.63 [1.13-2.34],0.0090080327742353
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,15833,164,0.97 [0.63-1.49],0.8936645320464056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18619,198,1.20 [0.80-1.79],0.3763875922245602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,16091,168,0.76 [0.49-1.20],0.2408064682576442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18530,199,1.63 [1.08-2.48],0.0214482601240901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18371,192,1.70 [1.15-2.53],0.0082535282484599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,15701,162,0.84 [0.62-1.13],0.2531706044566469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,18509,197,1.06 [0.94-1.19],0.3627051270147831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,18138,192,1.04 [0.75-1.46],0.8087827224222373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,16059,167,1.44 [0.92-2.27],0.1133770450471329
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,18792,201,0.88 [0.40-1.94],0.7574349344012179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18553,197,1.11 [0.90-1.36],0.3209447135438695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,16113,168,1.12 [0.92-1.36],0.2636280805224065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,15661,160,1.12 [0.98-1.27],0.1009448725880207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",16084,168,1.09 [0.86-1.39],0.4818222402586739
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",16003,167,1.08 [0.94-1.23],0.2839468493231397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15585,161,1.04 [0.83-1.31],0.7254305855276213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15661,160,1.33 [0.98-1.81],0.0688178385981315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,18405,192,1.07 [0.85-1.34],0.5854774943736044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,15627,160,1.09 [0.92-1.29],0.3216251519185413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18563,201,1.06 [0.88-1.29],0.5385073734383308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18783,201,1.07 [0.95-1.22],0.269045765513159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,16091,168,1.11 [0.89-1.39],0.3411429791114243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,15585,161,1.35 [1.02-1.79],0.0388536378278958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,18250,194,1.09 [0.73-1.62],0.6809605693930929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,16091,168,1.07 [0.90-1.27],0.4438052170322422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,15625,163,0.92 [0.76-1.11],0.3718997798326888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELN,Elastin,16113,168,1.53 [0.99-2.38],0.0544149471323751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18466,193,1.18 [0.97-1.43],0.1054333497046518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,15585,161,1.10 [0.76-1.60],0.6053119439988432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,18250,194,1.03 [0.79-1.35],0.8120919340695516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,14868,157,1.30 [0.99-1.70],0.0563430542938202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,18792,201,1.81 [0.89-3.67],0.0991363231336532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,18548,201,1.14 [0.97-1.34],0.0995103998981606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,18728,202,1.09 [0.90-1.32],0.3652877647744117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,15661,160,0.89 [0.68-1.15],0.3682887622131905
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,16057,169,1.15 [0.92-1.45],0.2211180691687627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15585,161,1.26 [0.75-2.09],0.3833448087213286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,15585,161,0.76 [0.49-1.17],0.2078787993706327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18792,201,0.66 [0.39-1.12],0.125456406793562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18620,198,0.81 [0.63-1.04],0.0967122401602393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15661,160,1.48 [0.96-2.27],0.0771832652650552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17974,192,1.02 [0.87-1.20],0.78512389461236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,16057,169,1.14 [0.87-1.49],0.333475694213706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,18138,192,1.15 [0.85-1.56],0.3569413662359328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18233,194,1.32 [0.73-2.38],0.3575937860344678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18233,194,1.03 [0.65-1.63],0.8949459209726666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15661,160,0.94 [0.73-1.22],0.6562870050182279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,15627,160,1.65 [1.13-2.41],0.0095820626570443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,15701,162,0.93 [0.72-1.20],0.590969266780971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,18524,197,1.06 [0.93-1.21],0.410134278556125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,16057,169,0.86 [0.59-1.26],0.4345862167463601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,18586,198,0.94 [0.63-1.40],0.7528215319512603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,18163,194,0.94 [0.76-1.15],0.5322574398621248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17902,181,1.67 [1.12-2.50],0.0125225919972842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15754,159,1.10 [0.65-1.87],0.7150788576203133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18792,201,1.66 [1.03-2.69],0.0377726689738458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18377,192,1.54 [1.03-2.29],0.0332945424893947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,18233,194,1.02 [0.83-1.26],0.82633995227488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,15833,164,0.80 [0.54-1.18],0.2603551294990455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18553,197,1.04 [0.87-1.24],0.6479764467355111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,15661,160,1.09 [0.88-1.34],0.437880426724071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18707,199,1.24 [0.82-1.88],0.3084291698053614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,18603,198,0.86 [0.51-1.45],0.5778119593873741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,18467,197,1.30 [0.69-2.43],0.4202788451296256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,18603,198,0.96 [0.56-1.64],0.8680854306782566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,18466,193,1.08 [0.95-1.22],0.2424436380502872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,15701,162,1.08 [0.89-1.30],0.4387225506000219
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,15554,161,1.33 [1.00-1.77],0.0512631437868011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,18377,192,1.08 [0.93-1.27],0.3144111799559695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15833,164,1.28 [0.85-1.93],0.2429134884588145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,15627,160,0.86 [0.61-1.22],0.4031065549057079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,16057,169,0.97 [0.64-1.46],0.8887127288400658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,15754,159,1.11 [0.97-1.26],0.1193396946875409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,18439,192,1.27 [0.78-2.09],0.3332818984095272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15585,161,0.65 [0.43-0.98],0.0383454214589946
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,18792,201,1.22 [0.83-1.78],0.3184502261287397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,18529,197,1.21 [0.84-1.75],0.3058848083465967
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,15554,161,0.89 [0.66-1.20],0.4446263432245009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,15627,160,1.06 [0.82-1.36],0.6648906809457624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,16084,168,1.09 [0.91-1.30],0.3486838500390079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,15554,161,0.74 [0.47-1.17],0.1993638089930786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,15627,160,1.04 [0.88-1.23],0.6533416934335247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,15833,164,1.12 [0.72-1.76],0.6161516969019896
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,15585,161,1.19 [0.95-1.49],0.1220620567847458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,15585,161,1.14 [0.86-1.51],0.3533943675634187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18728,202,1.09 [0.65-1.83],0.7360340406519146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,16132,167,0.96 [0.58-1.60],0.8700775467116969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,15908,164,1.19 [0.78-1.82],0.4266056029897436
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,18561,199,1.04 [0.83-1.30],0.726152004542902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,16135,166,0.91 [0.63-1.30],0.5892676125553433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,16066,165,0.76 [0.43-1.36],0.3601290283276903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,16135,166,1.18 [0.44-3.15],0.7406998604232614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,18598,197,1.15 [0.92-1.43],0.2100389694808407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,18616,200,1.54 [0.95-2.50],0.0782303889257562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,18620,198,0.97 [0.65-1.46],0.884896991378625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,18627,198,0.38 [0.20-0.72],0.0031654579583285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",18529,197,1.01 [0.88-1.15],0.9154225455035576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",18563,201,1.04 [0.89-1.21],0.6130261065216871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",16113,168,1.05 [0.79-1.38],0.7506713161587911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",18792,201,1.08 [0.83-1.39],0.5763566179096615
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,18667,201,1.18 [0.98-1.41],0.0774468502955158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,18203,194,1.15 [0.93-1.42],0.2070311434792345
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,18553,197,1.05 [0.84-1.31],0.6920943752325545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,18563,201,1.04 [0.88-1.23],0.6403853489867664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,16059,167,1.15 [0.93-1.42],0.1992528302132195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,16091,168,0.98 [0.89-1.08],0.745056241175205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,16057,169,1.15 [0.70-1.89],0.5795977572932184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,15661,160,1.28 [1.00-1.64],0.0489809684850316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,16113,168,0.67 [0.39-1.15],0.1483267778153194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,18466,193,1.53 [1.04-2.24],0.0312028603190782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,18543,201,1.48 [0.97-2.24],0.066097760724156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,16059,167,1.03 [0.87-1.22],0.7209118029964252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,18792,201,1.03 [0.65-1.64],0.8944032865316485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,15701,162,1.08 [0.88-1.32],0.4877760289915328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,18732,201,1.07 [0.75-1.52],0.7261631538441657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,18783,201,1.23 [0.87-1.73],0.2447737839877556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,16119,165,1.71 [1.06-2.77],0.0283618596227914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,15701,162,0.91 [0.70-1.17],0.4595974262704977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",18563,201,0.83 [0.70-1.00],0.0446396295774837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16113,168,0.90 [0.73-1.10],0.3002795765187978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,18553,197,0.85 [0.65-1.11],0.2234634191312968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,16091,168,0.79 [0.42-1.48],0.4635956753915258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18561,199,0.99 [0.77-1.28],0.9504831612685138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18503,197,0.96 [0.78-1.18],0.6875089401591642
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18138,192,1.06 [0.85-1.32],0.6017816391534361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18593,198,0.92 [0.71-1.19],0.5228853284629009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,16111,167,1.02 [0.78-1.33],0.8757406061838379
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,18501,198,0.79 [0.58-1.06],0.1141366829583668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18563,201,0.99 [0.74-1.32],0.9493320578005138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18699,201,1.22 [0.95-1.57],0.115015938950563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18250,194,1.12 [0.88-1.42],0.3519444458751932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18561,199,0.77 [0.62-0.96],0.0194413159946292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,18553,197,0.91 [0.76-1.10],0.3278205705221892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,18138,192,1.09 [0.89-1.33],0.4112973323316303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",15585,161,1.17 [0.95-1.44],0.1346377192226018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",15585,161,0.90 [0.68-1.20],0.4763477818127275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,18138,192,1.08 [0.91-1.28],0.4012156690118497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,18138,192,1.10 [0.86-1.42],0.4488344887867042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,18627,198,0.74 [0.54-1.01],0.0539410530246737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,15764,159,0.92 [0.56-1.53],0.7594276814557128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",16091,168,1.09 [0.91-1.30],0.3701749027702626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,15627,160,1.26 [1.01-1.57],0.0366006833796453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,15627,160,1.43 [1.09-1.87],0.0100922278897105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,18620,198,1.07 [0.91-1.26],0.4116637020033453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18553,197,1.05 [0.88-1.26],0.5710647754390146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,15627,160,1.38 [1.05-1.81],0.0200537334442224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,18714,201,1.04 [0.94-1.16],0.4680491188690101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,18707,201,1.17 [0.93-1.48],0.1727765541971068
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,15627,160,1.00 [0.60-1.65],0.9883646797127656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,18250,194,1.24 [0.85-1.80],0.2716151688468158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,15627,160,1.13 [0.79-1.61],0.4954381940603231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,15554,161,1.00 [0.82-1.22],0.9846086141607536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,15526,160,1.19 [0.81-1.74],0.375299695539814
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,18603,198,1.22 [0.83-1.78],0.3115754746568159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,16119,165,0.85 [0.63-1.14],0.2766345138357535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,16084,168,1.42 [0.95-2.11],0.0841860863205815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,18603,198,1.15 [0.64-2.04],0.6399866792848676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,15754,159,0.87 [0.65-1.17],0.358251766772142
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,16132,167,0.86 [0.68-1.08],0.1922870981086427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,18163,194,1.08 [0.89-1.31],0.4281910085147875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",15625,163,0.92 [0.76-1.13],0.4406483078163919
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,15585,161,1.22 [0.92-1.61],0.1609812737453873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,18163,194,1.09 [0.91-1.30],0.3570402555698234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,18528,198,1.10 [0.94-1.30],0.2296702539233403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,16091,168,1.10 [0.95-1.28],0.198618284615961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18630,199,1.01 [0.91-1.13],0.8313098595795426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18405,192,1.02 [0.75-1.38],0.896449513840543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18405,192,1.06 [0.93-1.22],0.3901759841630553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,18135,194,1.01 [0.76-1.33],0.9620076534251704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,16059,167,1.16 [0.91-1.48],0.2365792379391191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,18138,192,1.06 [0.95-1.19],0.3100175792951608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18405,192,1.37 [0.88-2.14],0.1681388141342049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,18429,193,1.87 [1.09-3.23],0.0233166456782251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,18138,192,1.51 [1.05-2.16],0.0249657456633543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,18783,201,0.59 [0.41-0.83],0.0028606969648869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,18603,198,1.09 [0.75-1.58],0.6652081471577285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,18163,194,1.15 [0.98-1.35],0.0903160461606077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,18138,192,1.00 [0.69-1.44],0.9994228972601484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,16135,166,0.77 [0.44-1.34],0.358642142021945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,16084,168,0.77 [0.56-1.05],0.0937161704803945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,16057,169,0.93 [0.60-1.43],0.7341084623848162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,15627,160,1.08 [0.95-1.22],0.2592634729500325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,18519,196,0.86 [0.55-1.35],0.5075017155532329
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18728,202,1.15 [0.75-1.77],0.510396656690679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,18547,198,1.02 [0.96-1.09],0.4983023570676973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,15526,160,0.71 [0.46-1.10],0.1236402181891432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,18163,194,1.07 [0.77-1.47],0.6876706238812496
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,15627,160,1.11 [0.80-1.53],0.5397174535234284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,18553,197,1.09 [0.94-1.27],0.2344235632618133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,18138,192,1.13 [0.99-1.28],0.0661879803302862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,15585,161,1.07 [0.86-1.32],0.5638954070151858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,15701,162,0.96 [0.61-1.50],0.8437474514096548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,18349,192,0.93 [0.55-1.58],0.7834119595327902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15661,160,1.14 [0.81-1.59],0.4580894694177048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FST,Follistatin,18598,197,1.19 [0.92-1.54],0.1798878840857561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,15661,160,2.00 [1.03-3.86],0.0400177599622007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18499,197,1.32 [0.89-1.97],0.1724063406061302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,16046,168,0.93 [0.78-1.11],0.4318382152383705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,18662,200,0.96 [0.83-1.12],0.6232666882159278
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,15754,159,0.87 [0.68-1.12],0.281761881462289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FURIN,Furin,18603,198,0.98 [0.67-1.45],0.922454087085896
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,18108,192,1.41 [1.05-1.89],0.0228011674918223
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15805,163,0.91 [0.70-1.19],0.507412053301843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18728,202,0.94 [0.72-1.24],0.683022474787347
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",18405,192,0.88 [0.71-1.11],0.2819373765091266
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",18737,201,1.04 [0.88-1.23],0.6531762234562102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,18250,194,1.11 [0.92-1.35],0.2788301393541325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,18523,199,1.08 [0.94-1.24],0.2678760433366625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,15701,162,0.70 [0.50-0.98],0.0399805231655975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,15625,163,1.10 [0.79-1.53],0.5674784148886132
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,16057,169,0.92 [0.66-1.28],0.629119375965245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15833,164,1.10 [0.90-1.34],0.3723403607763965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15625,163,0.94 [0.73-1.21],0.6509540423561321
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,15554,161,1.07 [0.60-1.92],0.8127456104505201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,15627,160,0.85 [0.59-1.23],0.3982068765063412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15833,164,1.03 [0.77-1.38],0.8227523233212546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15661,160,1.33 [1.02-1.74],0.0386136568160267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,15554,161,0.99 [0.79-1.26],0.962613979643252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,18620,198,1.30 [1.07-1.57],0.0071250375573394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18466,193,1.18 [0.74-1.87],0.4848001923414052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18737,201,0.83 [0.52-1.33],0.4386470957279105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18250,194,0.87 [0.64-1.17],0.3516396546901731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,16113,168,1.10 [0.65-1.83],0.7293569295932143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18466,193,1.54 [0.83-2.86],0.1756585831062427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,15585,161,0.66 [0.38-1.13],0.1301553940548147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15411,158,1.27 [0.75-2.14],0.3735230553543037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,16091,168,0.99 [0.56-1.74],0.9738619816962936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,15833,164,1.01 [0.75-1.34],0.9696499948372342
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,18672,200,1.03 [0.62-1.72],0.8948031344868735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,15585,161,1.12 [0.79-1.60],0.5276328296496872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,16084,168,1.05 [0.95-1.17],0.3579607204974832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15554,161,0.73 [0.41-1.31],0.2944109051319373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15661,160,1.18 [0.97-1.43],0.09718025991072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,15701,162,1.02 [0.77-1.35],0.8771694429361607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,16056,168,0.94 [0.74-1.18],0.5829003771341372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,18250,194,1.09 [0.89-1.35],0.3922428261117582
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,18163,194,0.96 [0.74-1.26],0.7704016213890498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,15585,161,0.84 [0.57-1.24],0.3806716871415659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,16135,166,1.45 [0.82-2.54],0.1973019266800346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,16084,168,1.07 [0.94-1.23],0.304266639730681
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,18138,192,1.02 [0.92-1.13],0.7252430170959755
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15377,156,0.88 [0.63-1.23],0.4541266966792696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,15585,161,0.99 [0.70-1.40],0.9463941107861836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18466,193,1.17 [0.81-1.70],0.4094127997539728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18792,201,1.22 [0.93-1.61],0.1568275939550127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18563,201,0.97 [0.68-1.38],0.8559879133463038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,18163,194,1.22 [0.88-1.70],0.2335655686860475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,16113,168,1.00 [0.75-1.33],0.9979877087969544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,18107,191,1.12 [0.85-1.48],0.4108693918369998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,18138,192,1.02 [0.83-1.25],0.8366252408973094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,18138,192,1.04 [0.95-1.15],0.3797315989576623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18714,201,1.03 [0.65-1.63],0.8977663667941722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,18466,193,0.79 [0.43-1.48],0.4664719214348084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,18349,192,1.45 [0.92-2.28],0.1125061890577688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,15619,163,1.14 [0.89-1.44],0.2950819037913919
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,18163,194,1.07 [0.89-1.27],0.4677718107301984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,16113,168,1.08 [0.87-1.33],0.4866963303494752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,16086,168,1.01 [0.74-1.37],0.9598369114383976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,18266,196,0.81 [0.55-1.18],0.2687958959526101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,18530,199,0.89 [0.68-1.16],0.3797521574038561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,18405,192,1.37 [0.80-2.33],0.2478333235576654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,18543,201,1.05 [0.98-1.12],0.1761299083342823
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,18138,192,1.00 [0.92-1.08],0.91528397597364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,15754,159,0.83 [0.48-1.44],0.5050472985308363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,18163,194,0.96 [0.75-1.23],0.7395170329233847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,18563,201,1.00 [0.86-1.16],0.9730846811782724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,16091,168,1.06 [0.69-1.61],0.7971748234125455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,16091,168,1.11 [0.92-1.35],0.2669612506104133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,15754,159,1.04 [0.64-1.68],0.8697970269985188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,15554,161,1.21 [0.92-1.60],0.1632232964433705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,15661,160,1.26 [0.96-1.65],0.094290956337743
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,16084,168,1.16 [0.72-1.87],0.5417863139982771
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,16059,167,1.05 [0.91-1.23],0.5006859497104108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,15627,160,0.99 [0.70-1.39],0.956859908185474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,15627,160,1.13 [0.97-1.32],0.1282563706029484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,15554,161,0.94 [0.73-1.22],0.6439529008231377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,17817,189,1.13 [0.71-1.80],0.611294869674534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,15727,159,0.83 [0.55-1.24],0.3565617076362609
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,18405,192,0.96 [0.71-1.29],0.7684134138546419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,15627,160,1.22 [0.81-1.86],0.3436903562906047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,18233,194,1.08 [0.86-1.35],0.5169566960668203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,18506,197,1.20 [0.83-1.73],0.3319386942338127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,15625,163,0.86 [0.56-1.33],0.5005061678803046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,18439,197,0.98 [0.78-1.22],0.8385882699967626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15754,159,1.08 [0.91-1.28],0.3952574251374825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18163,194,0.97 [0.72-1.30],0.8313755717104573
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,16057,169,1.24 [1.01-1.53],0.0434020373103811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,15729,161,1.00 [0.66-1.52],0.999323898208608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,16113,168,1.06 [0.87-1.31],0.5543273063635288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,18783,201,1.11 [0.85-1.44],0.4537960671118134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,15754,159,1.20 [0.95-1.50],0.1224157962424339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,16091,168,1.09 [0.92-1.28],0.3213187631809148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,18138,192,1.01 [0.83-1.23],0.8892357608755441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15701,162,1.04 [0.78-1.40],0.7789481839713939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,18561,199,0.92 [0.73-1.16],0.4982068019968565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,15661,160,0.90 [0.56-1.47],0.6807571175044196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,15754,159,1.15 [0.76-1.74],0.5107375359702417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,16091,168,1.13 [0.94-1.36],0.1921895755321004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18728,202,0.94 [0.53-1.64],0.8205581709917062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18553,197,1.06 [0.94-1.21],0.3256398050071099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,16059,167,1.13 [0.83-1.54],0.4260705211562968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",16119,165,0.83 [0.58-1.20],0.3320900364191029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,18509,198,1.33 [0.92-1.93],0.1317054303859431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,15585,161,0.97 [0.77-1.21],0.7723405210455678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,18002,194,1.06 [0.91-1.23],0.4678809070541303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,15754,159,1.50 [0.97-2.34],0.071301186869013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,18523,199,1.05 [0.91-1.21],0.484366018983552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,18466,193,1.04 [0.95-1.14],0.4171083707304274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,18737,201,0.84 [0.55-1.28],0.4172080341758908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,18405,192,1.00 [0.80-1.26],0.9669708554189652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,16057,169,1.07 [0.80-1.41],0.6585269469039133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,16059,167,0.92 [0.64-1.32],0.6534653733738545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,16132,167,1.03 [0.75-1.40],0.8749123486312264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,16059,167,1.30 [1.03-1.63],0.026636277677654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18163,194,0.91 [0.58-1.42],0.6731052952875791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,18069,194,1.04 [0.67-1.63],0.8598029596756136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,15625,163,1.09 [0.85-1.40],0.5018310145608982
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,16091,168,1.06 [0.69-1.63],0.7833557462694853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,16059,167,1.12 [0.88-1.42],0.3683214046260687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,18233,194,1.05 [0.86-1.29],0.6076580930806541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,16057,169,0.99 [0.75-1.30],0.9409992129909952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,18563,201,1.04 [0.95-1.15],0.3988647732283684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,16113,168,0.98 [0.77-1.24],0.8451068824674386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",16091,168,1.10 [0.80-1.52],0.5462840248984825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15625,163,1.21 [0.98-1.50],0.0834463767466477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,18233,194,1.18 [0.94-1.48],0.1440352027896058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18461,198,1.52 [0.90-2.55],0.1148409597395522
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,15661,160,1.22 [0.91-1.63],0.1824962765689169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",18466,193,1.08 [0.87-1.34],0.4608176209257787
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,15466,160,1.00 [0.84-1.21],0.9681808218640198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,18138,192,1.08 [0.95-1.24],0.2379788153108254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,16063,166,1.36 [0.62-3.01],0.4451169745458179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",16048,167,0.66 [0.33-1.31],0.2366260342815007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,18533,200,0.92 [0.78-1.07],0.2624804858544156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,18138,192,0.89 [0.74-1.06],0.1826615833428201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,15585,161,0.98 [0.79-1.20],0.8219668368230473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,18049,193,0.92 [0.76-1.11],0.389522972423833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,16084,168,1.01 [0.95-1.07],0.8245040560389982
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15833,164,1.00 [0.80-1.25],0.9779206246742154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,15701,162,1.12 [0.93-1.35],0.2201731761450166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,18460,199,1.24 [0.86-1.79],0.2549632185077914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,15833,164,0.99 [0.82-1.19],0.8975001981774835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,15585,161,0.77 [0.49-1.20],0.2503313091180781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,18639,200,0.94 [0.77-1.16],0.5749746883374359
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",18233,194,1.03 [0.90-1.18],0.6660830874147523
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18783,201,0.94 [0.65-1.37],0.7637606042571073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,18553,197,0.97 [0.80-1.18],0.776918986264017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18233,194,0.99 [0.84-1.17],0.9162358806815458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,15554,161,1.11 [0.86-1.43],0.4173172831087444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15585,161,1.18 [0.99-1.40],0.0580199089684497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18687,200,1.03 [0.86-1.23],0.7551393018976498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,18737,201,0.98 [0.88-1.08],0.6675076005680771
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",18561,199,1.10 [0.94-1.30],0.2391821707556448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,18710,200,1.19 [0.98-1.45],0.0820183229232412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18561,199,1.29 [0.90-1.84],0.1625796273257467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,18687,200,1.04 [0.88-1.23],0.6576481820335234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,18737,201,1.09 [0.90-1.33],0.371656963869679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,16113,168,1.06 [0.93-1.22],0.3731590123648363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,15585,161,1.26 [1.05-1.52],0.0133678566799595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,18783,201,1.21 [0.97-1.52],0.0948649850916581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,15627,160,1.28 [1.07-1.55],0.0081092124699128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,15625,163,0.92 [0.71-1.17],0.4886224738385953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,16059,167,1.05 [0.75-1.48],0.7578181628948868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,18702,201,1.14 [1.00-1.31],0.0485877520857975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,16084,168,1.12 [0.90-1.39],0.3221178681217534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,18233,194,0.88 [0.68-1.13],0.314427902438636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,15754,159,0.96 [0.54-1.71],0.9003103349346084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,16084,168,1.14 [0.81-1.60],0.4628237400423733
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,16113,168,1.27 [0.72-2.22],0.4071291394146205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,18553,197,1.08 [0.92-1.26],0.3366258196530392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,18783,201,1.06 [0.74-1.53],0.7433235121634285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,15990,165,1.00 [0.57-1.75],0.991848809388416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,18138,192,1.14 [0.97-1.34],0.122746785790625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,16084,168,1.12 [0.92-1.35],0.2588964253576048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,15627,160,1.14 [0.92-1.40],0.2426251162585674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,15585,161,0.82 [0.50-1.34],0.426090488728693
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,16049,168,1.06 [0.78-1.45],0.6946993532728066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,16091,168,1.18 [0.85-1.62],0.3210948345730711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,18233,194,1.20 [0.75-1.91],0.4421848724346443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",16091,168,1.60 [1.02-2.53],0.0425167461050986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18489,195,0.98 [0.69-1.39],0.8945482718735158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18553,197,1.01 [0.65-1.57],0.9555496382867918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,18737,201,1.09 [0.80-1.48],0.5763855184652578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,15724,159,0.83 [0.64-1.08],0.1586874066049193
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15661,160,1.32 [0.99-1.76],0.0599149761479537
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15585,161,1.11 [0.80-1.55],0.5223356989238788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,15516,161,1.12 [0.84-1.48],0.4392275436028877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,18362,197,0.82 [0.63-1.07],0.1379816443700907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18163,194,1.02 [0.78-1.34],0.8821171009667843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,15701,162,0.96 [0.76-1.20],0.7143430408267749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,18321,192,1.20 [0.92-1.58],0.1747170255452741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18168,194,1.02 [0.86-1.20],0.8257479865111615
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,16091,168,1.07 [0.81-1.42],0.6325485752840714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,18783,201,1.10 [0.93-1.30],0.2817361914143089
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,18138,192,1.13 [0.81-1.58],0.4667514153933564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,15924,164,1.02 [0.87-1.19],0.8410757569416543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,15804,164,1.03 [0.89-1.20],0.7143503125489435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15661,160,1.18 [0.74-1.89],0.4809936298596986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,16066,165,0.80 [0.50-1.28],0.3566891138252613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,15661,160,1.11 [0.94-1.32],0.2173145937945595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18466,193,1.20 [0.85-1.69],0.2970753318266931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18737,201,0.98 [0.68-1.40],0.8948604740595253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15627,160,1.07 [0.71-1.62],0.7388086166520235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,15661,160,1.03 [0.88-1.21],0.7273279652208469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18553,197,1.51 [1.09-2.07],0.0119934914281861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,16084,168,0.91 [0.72-1.16],0.4537808311550246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,15585,161,1.14 [0.85-1.52],0.3837623017231314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15661,160,1.27 [0.93-1.72],0.1311874443503252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,18079,193,1.19 [1.02-1.40],0.0284356947190186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,18586,198,1.08 [0.91-1.29],0.3646362805709853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,16057,169,1.35 [0.95-1.92],0.0935252557079446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,18266,193,1.13 [0.93-1.36],0.2080695409197844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,18737,201,1.10 [0.81-1.50],0.5336600874787949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18448,197,1.19 [0.74-1.93],0.4705102116203131
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,15625,163,0.99 [0.80-1.23],0.93680075080738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,15625,163,0.86 [0.60-1.24],0.4147359933359531
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",18603,198,1.07 [0.87-1.31],0.5480204153006267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,18485,196,0.90 [0.51-1.58],0.7099992769891009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18792,201,1.45 [0.84-2.49],0.184570648011576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,18250,194,1.18 [1.01-1.39],0.0345427215736406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18504,198,0.85 [0.54-1.33],0.4763247498032873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18792,201,1.38 [0.94-2.02],0.1021644999198949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18792,201,0.80 [0.49-1.30],0.3697695243759332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,18553,197,1.08 [0.85-1.38],0.5122587720953382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,18563,201,1.15 [0.88-1.51],0.3109292986259167
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,18466,193,2.75 [1.40-5.39],0.003197430460306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,15833,164,0.90 [0.62-1.31],0.5882547785674255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,18163,194,1.11 [0.86-1.43],0.4139435514703081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",15661,160,0.86 [0.66-1.10],0.2274831411873461
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,18783,201,0.92 [0.23-3.70],0.908566176486211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,18737,201,0.94 [0.73-1.23],0.6733021058759294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15694,164,1.07 [0.72-1.58],0.7397716505009038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15833,164,0.78 [0.57-1.07],0.1277305340016616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15833,164,0.88 [0.58-1.33],0.5453048370464577
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,16059,167,1.27 [0.73-2.21],0.394531692972343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,18250,194,1.03 [0.92-1.15],0.6452232102343813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18620,198,1.74 [1.01-2.99],0.0446543666527377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,18405,192,0.95 [0.74-1.22],0.6774742394584456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,18163,194,0.68 [0.50-0.92],0.0121421706322394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,15625,163,0.78 [0.57-1.07],0.1264187804969447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18553,197,0.77 [0.52-1.13],0.1839764855891497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,15585,161,1.04 [0.69-1.56],0.8432428624417015
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,15701,162,1.35 [1.00-1.82],0.0511143152033033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,16091,168,1.11 [0.87-1.41],0.4142957681012512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15625,163,1.10 [0.83-1.46],0.5129949706562018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,16119,165,1.44 [0.83-2.50],0.1927343671174625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,18466,193,1.65 [0.95-2.88],0.0769937675922745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15585,161,1.20 [0.90-1.60],0.2239656480046092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,18561,199,1.22 [0.72-2.07],0.4603860941423988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,18766,200,1.12 [1.01-1.24],0.0305147228702638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,18762,201,1.19 [0.96-1.46],0.1125986297067495
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,18649,198,0.79 [0.55-1.15],0.2226054091159755
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18335,196,1.28 [0.97-1.69],0.0855434786524443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,18500,197,1.12 [0.74-1.69],0.5800509733146544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,18792,201,1.04 [0.69-1.57],0.8601703163163714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18563,201,0.91 [0.62-1.35],0.6473812041509365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,15627,160,0.80 [0.61-1.06],0.1183753253371864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,15585,161,1.15 [0.91-1.47],0.2476831020394214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,16113,166,0.89 [0.47-1.69],0.7188091183856542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,15554,161,0.99 [0.84-1.17],0.916282460090243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,15661,160,1.02 [0.70-1.49],0.902958188633084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18466,193,1.19 [0.82-1.73],0.3609058102723274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,18563,201,1.01 [0.67-1.53],0.955885315688656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,16113,168,0.91 [0.76-1.09],0.3156117852644242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,18553,197,1.11 [0.97-1.28],0.1315132015364572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,18138,192,1.10 [0.97-1.25],0.1325907519018735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18250,194,0.88 [0.73-1.05],0.1419469790617719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,18250,194,0.99 [0.79-1.24],0.9458612427810688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18620,198,1.19 [0.78-1.83],0.4151095502006762
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,18250,194,1.10 [0.91-1.34],0.3049262473647956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18466,193,0.99 [0.83-1.17],0.8990593424336586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18783,201,0.93 [0.73-1.17],0.5127893689874958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18250,194,1.11 [0.78-1.56],0.5633478703651323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,15627,160,1.05 [0.73-1.51],0.7964004479055635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,18250,194,1.02 [0.79-1.31],0.9075779499876226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,18315,194,1.22 [0.71-2.10],0.461589870657547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,15625,163,0.91 [0.54-1.51],0.70468132764104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,18553,197,1.17 [0.80-1.71],0.4079301437267736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18250,194,1.45 [1.00-2.09],0.0481557438516399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18783,201,1.05 [0.79-1.41],0.7264002796354783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,18210,194,0.98 [0.73-1.33],0.9173236570212376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,18250,194,1.16 [0.99-1.37],0.0665782363306176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,18250,194,1.27 [0.96-1.68],0.0962124724957097
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,18250,194,0.99 [0.83-1.18],0.925916919839134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,18561,199,0.88 [0.66-1.17],0.3749805730007711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,18330,197,1.11 [0.88-1.40],0.3933259994020995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,18465,196,0.88 [0.66-1.17],0.373572099303181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18649,198,1.03 [0.68-1.57],0.8842215721953599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,18783,201,1.02 [0.70-1.50],0.9023480668638576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,18292,192,1.01 [0.94-1.09],0.7296671037007523
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,18098,197,1.21 [1.03-1.42],0.0185054970063203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,18250,194,0.93 [0.74-1.16],0.5223505643593143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,18163,192,1.01 [0.81-1.27],0.909500333097507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18530,199,1.28 [0.75-2.20],0.3624649072274091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,18500,197,0.96 [0.51-1.81],0.8919647117649334
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,18561,199,1.38 [1.06-1.80],0.0152106365186673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,18732,201,1.08 [0.82-1.41],0.579671696422595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,18250,194,1.17 [0.83-1.66],0.3676875106714236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,18499,198,1.02 [0.80-1.29],0.895724326447866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,18250,194,1.02 [0.68-1.52],0.9404782495122208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,18250,194,0.84 [0.62-1.13],0.2381555261731406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,18250,194,1.14 [0.89-1.46],0.2969904233293806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,15627,160,1.31 [0.93-1.84],0.1221739250618244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,15627,160,0.93 [0.69-1.24],0.6058430063313738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,16057,169,1.17 [0.96-1.44],0.1279478524090044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,18250,194,1.03 [0.78-1.37],0.8301217542069773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,18250,194,0.92 [0.70-1.20],0.5284181025315111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,15495,160,0.94 [0.60-1.47],0.7898396761008618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18444,198,1.28 [0.94-1.74],0.1214833442026933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,18250,194,1.04 [0.74-1.46],0.8120469706211195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,16057,169,0.96 [0.63-1.46],0.8472233427500322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,15554,161,1.18 [0.90-1.53],0.2241300689524834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,15627,160,0.97 [0.73-1.28],0.8186304588227938
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,15569,158,1.57 [1.05-2.36],0.027697494502837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,18553,197,0.91 [0.67-1.24],0.5540456477384735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,18250,194,1.23 [0.89-1.69],0.2141151707188061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,18132,193,0.80 [0.57-1.13],0.2121781003557349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,15627,160,0.92 [0.69-1.22],0.5496946158717921
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,15582,160,0.91 [0.71-1.16],0.4267160676943448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,18250,194,1.30 [0.88-1.93],0.1900743275974203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,18250,194,0.93 [0.82-1.05],0.2198657702511727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18553,197,1.20 [0.84-1.70],0.3118911484733775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,18250,194,1.03 [0.94-1.12],0.5615399383469518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18553,197,0.93 [0.74-1.17],0.5305622339710143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18466,193,1.00 [0.84-1.19],0.9789108616086698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,18479,198,0.81 [0.56-1.16],0.2491848815672446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,18563,201,0.94 [0.46-1.94],0.87231289265437
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,18553,197,1.03 [0.85-1.26],0.7520290705321402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,18561,199,1.26 [0.99-1.62],0.0613886568547549
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,15833,164,0.80 [0.58-1.12],0.1920149731701839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18132,194,1.13 [0.91-1.39],0.2681102564034769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,16057,169,0.97 [0.69-1.36],0.8687316647237362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,18405,192,1.04 [0.84-1.28],0.7184105994588696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,16084,168,1.14 [0.87-1.49],0.3467240213807839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,15625,163,0.79 [0.46-1.34],0.3813490522780779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,18135,194,1.31 [1.06-1.62],0.0119765301027507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,15754,159,1.09 [0.81-1.46],0.5867883199586179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,18561,199,0.92 [0.67-1.27],0.6228309234904654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,18466,193,1.18 [0.94-1.49],0.1615276760206441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15661,160,1.36 [1.06-1.76],0.0177759941464579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",16091,168,0.93 [0.64-1.35],0.7048122038701474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18466,193,1.13 [0.99-1.29],0.0615002886181742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,16084,168,1.05 [0.89-1.23],0.5931758916115295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,16057,169,1.10 [0.83-1.46],0.5125428009081439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,16059,167,1.00 [0.86-1.16],0.9561200676691988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,15627,160,1.30 [0.52-3.25],0.5700096038976774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,18371,192,1.05 [0.91-1.21],0.5039126915413183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,18466,193,1.15 [0.92-1.45],0.22907540610142
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18233,194,1.05 [0.92-1.21],0.4660291400318572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,18250,194,1.09 [0.91-1.31],0.3495748433484703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,18553,197,1.06 [0.93-1.19],0.3826490093652079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17886,191,1.15 [0.82-1.60],0.4269261597206766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,18553,197,1.13 [0.81-1.56],0.4819679720929652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,16119,165,0.72 [0.50-1.05],0.0908782993346959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,15932,166,1.06 [0.91-1.23],0.4852807953201263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18553,197,0.94 [0.64-1.36],0.7327392394286258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,15754,159,0.95 [0.61-1.48],0.8236632429218048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,18561,199,1.56 [0.94-2.59],0.0873920863702244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,18553,197,1.06 [0.84-1.35],0.6115998921296806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15627,160,0.99 [0.70-1.41],0.9738932451301034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,18561,199,1.09 [0.73-1.62],0.6753537961816016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,18737,201,1.27 [0.59-2.72],0.5414904802045373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,15833,164,1.12 [0.85-1.46],0.4183676264079176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,18563,197,1.20 [0.66-2.18],0.5582804356884528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,18138,192,0.81 [0.59-1.12],0.2037009574190004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,18233,194,1.06 [0.94-1.19],0.343673635767037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,18473,200,0.94 [0.60-1.49],0.8061296529190025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,18603,198,1.10 [0.79-1.52],0.5814040166987464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,18250,194,0.89 [0.58-1.35],0.5774448005029391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,18737,201,1.18 [0.91-1.54],0.210193513757557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,16119,165,1.30 [0.89-1.91],0.1797360221988718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,16135,166,1.03 [0.46-2.28],0.9476264535055864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18649,198,0.98 [0.70-1.36],0.8970550055061901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16135,166,1.15 [0.62-2.12],0.6534922673179598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,16057,169,0.88 [0.62-1.24],0.4527116493322402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,18553,197,1.08 [0.88-1.32],0.4620533386121761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,15585,161,0.97 [0.77-1.22],0.8065715778652236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15661,160,1.16 [0.95-1.42],0.1484746619729187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15625,163,1.36 [1.04-1.78],0.0254392813733364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18163,194,1.07 [0.84-1.36],0.5925330972732638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,15554,161,0.83 [0.58-1.20],0.331702107906807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,18728,202,1.40 [0.89-2.22],0.1480611390698074
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,15754,159,1.06 [0.79-1.43],0.6965559099834845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,18250,194,1.16 [0.95-1.43],0.1545236636942488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15554,161,1.07 [0.83-1.38],0.5913744190727575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,16059,167,1.08 [0.91-1.29],0.3582293127259818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18250,194,1.10 [0.87-1.40],0.41066769516563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18466,193,1.12 [0.84-1.50],0.4397742495430912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,16059,167,1.12 [0.97-1.29],0.1139667659709867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,15625,163,0.82 [0.59-1.13],0.2293686365831177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,15701,162,1.18 [1.01-1.39],0.0378236699186322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,18163,194,1.02 [0.80-1.30],0.8733810774579895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,15768,166,1.16 [0.85-1.58],0.342609112180732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,15627,160,1.06 [0.91-1.24],0.4393428348515253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,18603,198,0.90 [0.55-1.47],0.6837667445956206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,18163,194,0.90 [0.63-1.28],0.557104495209005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,15554,161,1.14 [0.94-1.37],0.1761096340734669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,15661,160,1.04 [0.81-1.33],0.7814309528443187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,16084,168,1.06 [0.67-1.69],0.8006847322949453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,15833,164,0.87 [0.71-1.08],0.2119274725657432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,15833,164,1.43 [0.89-2.29],0.1355394191080493
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,16057,169,1.10 [0.86-1.40],0.4643380555760134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,15585,161,1.34 [0.93-1.92],0.1131659644580082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,15625,163,0.92 [0.74-1.14],0.4381880363864173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,15585,161,1.11 [0.98-1.27],0.0933383651386527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,18466,193,1.03 [0.88-1.20],0.6976640875078838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,16057,169,0.95 [0.80-1.12],0.5122643086484504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,18138,192,0.97 [0.82-1.14],0.6832895895416775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,16059,167,0.95 [0.87-1.04],0.2995380702368028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18138,192,0.98 [0.89-1.09],0.7462051423633624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15554,161,0.98 [0.81-1.18],0.8046139330122983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,15625,163,1.00 [0.77-1.31],0.9897696465260064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,18163,194,1.05 [0.76-1.44],0.7850936268587199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,18627,198,1.56 [1.02-2.40],0.0422078031118058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,18563,201,1.03 [0.74-1.45],0.8508190642159398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,18163,194,1.16 [0.98-1.38],0.0822091314321134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,15625,163,0.90 [0.62-1.30],0.5756294218463318
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,16091,168,1.17 [0.90-1.53],0.249381887317676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,18384,195,0.98 [0.89-1.08],0.6963901109229093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,18550,198,1.06 [0.77-1.44],0.7332682870265566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,18416,195,1.20 [0.82-1.75],0.3394899993605661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,18138,192,1.00 [0.91-1.10],0.9921848657296564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,18126,190,0.95 [0.71-1.27],0.7464690995928676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,18737,201,0.91 [0.69-1.19],0.4809894738695434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,16026,169,1.00 [0.75-1.32],0.9796430575181972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,16119,165,1.00 [0.88-1.15],0.982092268395999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18737,201,1.31 [1.09-1.56],0.0035625316644567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,18566,198,1.44 [0.96-2.18],0.0793057249973476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,15372,157,1.37 [0.94-2.01],0.1020869623937859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,17926,186,1.33 [0.94-1.90],0.1108116100817709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,15817,163,0.97 [0.52-1.81],0.9201896188426544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18783,201,1.27 [0.92-1.76],0.1472471881569704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15625,163,1.01 [0.79-1.30],0.9121399221064694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,18783,201,0.93 [0.71-1.21],0.5940992614697027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,15627,160,1.08 [0.77-1.50],0.6658541857290108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,16084,168,1.00 [0.74-1.37],0.9769579782043092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",17603,184,1.24 [0.84-1.82],0.2800169086618373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",15585,161,1.14 [0.80-1.63],0.4690772213185739
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",18466,193,0.97 [0.83-1.14],0.7444686894623624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",18522,197,1.15 [0.95-1.38],0.1528210235615013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",18163,194,1.34 [1.07-1.67],0.0102352077664258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",15585,161,1.02 [0.68-1.53],0.9147810962394834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",15625,163,1.03 [0.85-1.23],0.7779533415065006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,18532,201,1.03 [0.83-1.29],0.7659867920976292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,18783,201,0.83 [0.62-1.10],0.2015649395658118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,18603,198,1.34 [0.87-2.05],0.1834451019622003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,16113,168,0.98 [0.83-1.15],0.7659190648950831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,16022,168,1.24 [0.95-1.62],0.1121131172073415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,18563,201,1.03 [0.85-1.25],0.7277599533917885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18466,193,1.08 [0.78-1.49],0.6457711652413695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18529,197,1.19 [0.85-1.67],0.3172911264337973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18405,192,1.02 [0.90-1.15],0.7555790437857113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,15585,161,1.00 [0.75-1.34],0.9952399199067742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,18620,198,1.22 [0.85-1.76],0.2858594379993056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,15661,160,1.23 [0.75-2.02],0.4170210895791054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,15685,161,1.26 [0.76-2.09],0.3659910586088784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,18004,197,1.15 [0.62-2.14],0.6590286493642498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,18750,201,0.82 [0.64-1.04],0.1072243939108951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,16057,169,1.09 [0.76-1.56],0.6264992986599134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,18250,194,1.04 [0.79-1.35],0.7984524308868044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,16057,169,1.27 [1.04-1.55],0.0167710931957281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,18783,201,1.07 [0.91-1.26],0.4261939323109391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,18466,193,1.05 [0.95-1.16],0.37361887888517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,15627,160,1.09 [0.92-1.31],0.3168398045918956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18377,192,1.31 [0.91-1.88],0.150236081778057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,18649,198,0.94 [0.76-1.17],0.5827923375887005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,18728,202,1.06 [0.89-1.26],0.5031147835342444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,16132,167,0.71 [0.36-1.40],0.3269189334235631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,16091,168,0.97 [0.76-1.25],0.8363636078358034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,18031,193,1.15 [0.83-1.60],0.3916828487326182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,16119,165,0.59 [0.42-0.84],0.0029591874359647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,18609,200,0.97 [0.76-1.25],0.8349825039403687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,16091,168,1.08 [0.93-1.25],0.3239872242550204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,16113,168,1.05 [0.84-1.32],0.6440057179376084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,18714,201,1.00 [0.79-1.28],0.9882540292629411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,15210,154,1.00 [0.79-1.26],0.9759261442140712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,15625,163,1.03 [0.84-1.27],0.7698362783555734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,16091,168,0.89 [0.53-1.49],0.6654043082864232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEP,Leptin,18563,201,1.04 [0.87-1.26],0.6416783450381804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,18563,201,1.05 [0.71-1.56],0.8104171542258403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,16091,168,1.12 [0.86-1.45],0.4197366868514252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,18563,201,0.96 [0.66-1.39],0.829445109962598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,18615,198,1.11 [0.73-1.70],0.6246463016867791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,16135,166,0.67 [0.39-1.13],0.129433482670368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,18529,197,1.03 [0.82-1.29],0.7943929012970578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,18526,193,1.17 [0.88-1.57],0.2764732961852689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,18728,202,1.12 [0.92-1.37],0.2644644671638775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18540,197,0.87 [0.57-1.34],0.5305280890363502
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,18620,198,0.98 [0.69-1.39],0.8984015201746328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,18138,192,0.95 [0.81-1.10],0.4793704755803336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18557,198,1.06 [0.86-1.31],0.5689544244987761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,18163,194,1.26 [1.03-1.54],0.0255427360201233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,18553,197,1.41 [0.83-2.38],0.2078054761346636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18561,199,1.18 [0.82-1.69],0.3749926695242451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,16119,165,0.99 [0.90-1.10],0.8695618148023374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15585,161,1.03 [0.77-1.39],0.8312748199458467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18543,201,0.94 [0.63-1.38],0.7375515948062117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,16113,168,0.88 [0.72-1.07],0.1846432556723916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18792,201,1.10 [0.70-1.74],0.6800027341821864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18702,201,1.14 [0.79-1.64],0.4855143712478066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18250,194,1.11 [0.83-1.49],0.4818079837205192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18792,201,0.89 [0.75-1.05],0.1654517523668657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,15661,160,0.87 [0.68-1.12],0.2911749469758385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,16031,166,1.10 [0.88-1.37],0.4018358312081211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,16084,168,1.29 [0.77-2.16],0.3266313283961319
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,16091,168,1.44 [0.99-2.10],0.0595237632721227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,15625,163,1.00 [0.78-1.29],0.9798385271176826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",15661,160,1.11 [0.93-1.32],0.2543994577754934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),15779,162,0.97 [0.90-1.06],0.5339082180861023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,18466,193,1.22 [0.98-1.52],0.0690611732792164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,18563,201,1.00 [0.77-1.29],0.9730387521091994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,17910,188,0.88 [0.71-1.10],0.2583093736836975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,15585,161,1.15 [0.91-1.45],0.2337396809746164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15585,161,1.21 [0.98-1.49],0.0806748178895965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15701,162,1.17 [0.87-1.57],0.3108619749206135
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16135,166,0.64 [0.36-1.13],0.1242358135366336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18687,200,1.01 [0.71-1.44],0.9473553550818932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15579,160,1.39 [0.86-2.25],0.1824010949503783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,18466,193,1.52 [0.96-2.41],0.072245170299804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,18563,201,1.24 [0.88-1.75],0.2161086718078633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,15701,162,0.93 [0.60-1.43],0.7263754680725887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,15701,162,1.11 [0.93-1.31],0.2469463707516732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18728,202,1.04 [0.84-1.29],0.707921255493636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18466,193,1.12 [0.81-1.56],0.4798588456983472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,16059,167,1.22 [0.87-1.72],0.2396661639672497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,15701,162,1.15 [0.85-1.55],0.3588169826431403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,16113,168,1.02 [0.76-1.39],0.8749229964188117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,16057,169,1.27 [0.95-1.68],0.1027562219552287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,18250,194,0.92 [0.67-1.27],0.6329286318788405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15701,162,1.15 [0.83-1.59],0.4019796889224302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,16091,168,1.07 [0.60-1.90],0.8143071747742601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,18138,192,1.12 [0.89-1.39],0.3333406795898704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,15833,164,0.88 [0.71-1.09],0.250444456512764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18553,197,1.30 [0.96-1.76],0.0911132512881929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,18553,197,1.28 [0.93-1.74],0.1278141312915661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,18737,201,0.97 [0.79-1.20],0.7988268121254153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,16057,169,1.34 [0.96-1.87],0.0831995641149819
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18792,201,1.32 [0.88-1.99],0.181819372162045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,18138,192,1.23 [0.99-1.54],0.0638995966604356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18437,197,1.39 [0.91-2.12],0.1305873707113746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,18250,194,0.97 [0.70-1.35],0.87447080588485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,16057,169,1.18 [0.86-1.62],0.2976116609053485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LXN,Latexin,18322,192,0.93 [0.77-1.13],0.4821495105263625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,18444,198,1.39 [1.02-1.89],0.0355388536635879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18553,197,1.53 [1.09-2.15],0.0143037443894483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18333,199,0.92 [0.59-1.43],0.7061458714170876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,18405,192,0.62 [0.43-0.89],0.0106760620101863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18138,192,1.11 [0.91-1.36],0.2993665998445884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,18466,193,1.06 [0.91-1.23],0.4506200320672969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,18163,194,1.02 [0.84-1.24],0.8253175076861188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,18461,196,1.23 [0.85-1.80],0.2730360353956093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,18138,192,0.93 [0.71-1.22],0.6120981232538026
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,15625,163,1.05 [0.92-1.20],0.4364605472131188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15701,162,1.05 [0.91-1.20],0.5211144650719682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16135,166,1.52 [0.71-3.25],0.2838293930945491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,15554,161,1.31 [0.90-1.90],0.1556053719190584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,15754,159,1.16 [0.94-1.43],0.1749696910197138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,15661,160,1.15 [0.80-1.66],0.4541082475798483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18348,192,1.13 [0.90-1.42],0.2756766846712751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,18138,192,1.23 [0.91-1.68],0.1812376839512869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,15701,162,0.98 [0.72-1.34],0.914109385358213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,15833,164,0.94 [0.80-1.12],0.5021421377201929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,18138,192,1.14 [0.88-1.48],0.311614751248613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,16113,168,1.47 [0.98-2.22],0.0620607783526238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,16057,169,0.88 [0.67-1.16],0.3658452957001256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15661,160,0.94 [0.51-1.72],0.8354698116159005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,16113,168,1.06 [0.83-1.36],0.6241039601494072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15554,161,1.44 [1.11-1.86],0.0058516227558228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,18620,198,1.05 [0.95-1.17],0.3572097292191045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,18603,198,1.68 [1.08-2.61],0.0206419594216779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,15585,161,0.83 [0.66-1.04],0.1115555456461128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15625,163,0.85 [0.53-1.37],0.5015095105396181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15585,161,1.02 [0.82-1.28],0.8301364745785489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,16084,168,1.21 [0.89-1.63],0.2180570212310009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,16059,167,1.07 [0.85-1.35],0.5695286565754483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18553,197,1.01 [0.89-1.15],0.8614235041254781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,18138,192,1.07 [0.94-1.22],0.2948311998450179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18377,192,1.08 [0.96-1.21],0.2072527786068073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,15554,161,1.24 [0.91-1.69],0.1688093113117041
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,18553,197,1.07 [0.80-1.44],0.6582437268171284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,15833,164,1.06 [0.87-1.30],0.5674133091086404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,15554,161,1.08 [0.99-1.18],0.0899021405061325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,18163,194,0.96 [0.75-1.22],0.7475896702998959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,18563,201,1.16 [0.71-1.91],0.5506967487446424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",15727,159,1.17 [0.98-1.39],0.0922325050895622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,18377,192,1.08 [0.62-1.90],0.7744491901285362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,18559,197,1.06 [0.69-1.65],0.7876308684664721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,18371,192,1.30 [0.89-1.90],0.1713745128337622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,18138,192,1.10 [0.95-1.26],0.1912016774194067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAX,Protein max,18163,194,1.07 [0.95-1.21],0.255940986985667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,18792,201,1.01 [0.81-1.27],0.9050891453425602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,15919,164,1.04 [0.91-1.19],0.5831323851770505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,18649,198,0.99 [0.67-1.47],0.954385141943063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",16091,168,0.97 [0.68-1.40],0.8773953899505962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,15627,160,0.99 [0.83-1.18],0.9034506572551386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,18465,200,1.09 [0.83-1.44],0.5360020984051593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,16059,167,1.36 [0.84-2.20],0.2095179763414985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18405,192,0.88 [0.73-1.06],0.1768308560517497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",16050,167,1.08 [0.75-1.57],0.6714992430381302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDK,Midkine,18539,197,1.13 [0.90-1.44],0.2955302617667564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,15701,162,1.16 [0.72-1.87],0.5541997356494269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15661,160,1.15 [0.98-1.36],0.0928015631840875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,18138,192,1.15 [0.97-1.36],0.1131517846899645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,15585,161,1.05 [0.78-1.40],0.7429523669858372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,18529,197,1.45 [1.06-1.99],0.0192693260729856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,15585,161,0.92 [0.57-1.51],0.7528250881967953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,18732,201,1.39 [0.73-2.63],0.316877272007438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,16113,168,0.69 [0.42-1.13],0.1378728152055655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,15754,159,0.79 [0.41-1.51],0.4702276631349946
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,16059,167,1.01 [0.83-1.24],0.9197075238359708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,18563,201,0.95 [0.85-1.06],0.3498226341335424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,18529,197,1.22 [0.70-2.12],0.4755603343181535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,18783,201,1.41 [0.85-2.35],0.1870625338895059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,18561,199,1.05 [0.95-1.16],0.3434189219961203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,18608,200,1.40 [0.73-2.67],0.3120888717742214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,18163,194,1.46 [0.99-2.14],0.0561773426834016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18553,197,1.03 [0.88-1.20],0.7216149498399858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,18714,201,1.04 [0.83-1.30],0.7411018181877602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,18233,194,0.98 [0.74-1.29],0.8710244061063892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,15701,162,1.02 [0.81-1.28],0.8818100141344505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,15754,159,1.23 [0.76-1.98],0.395905120324079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,18792,201,1.13 [0.83-1.55],0.4425225243641438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,18561,199,1.02 [0.77-1.35],0.914429551734702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,18598,197,1.08 [0.93-1.24],0.3297551598814746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,18553,197,1.01 [0.91-1.12],0.8935910304565465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,18603,198,1.23 [0.88-1.73],0.2178442237015359
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,15701,162,1.15 [0.94-1.41],0.1827019612527388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18553,197,1.00 [0.92-1.08],0.9135443990821162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,18525,198,1.12 [0.93-1.35],0.2455997604087205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,18250,194,1.12 [0.88-1.44],0.3575966879073989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,16057,169,1.08 [0.94-1.24],0.2865528649390859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,16084,168,1.07 [0.91-1.25],0.4369368749983394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,18405,192,1.08 [0.94-1.23],0.2683500514012182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,15627,160,1.19 [0.85-1.65],0.3122432071547357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,15554,161,0.97 [0.76-1.23],0.7830223557853502
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,18553,197,0.98 [0.85-1.14],0.8300821765598134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,18466,193,0.92 [0.77-1.09],0.3212770634778006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,17941,190,1.02 [0.88-1.18],0.7912713084220457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,18506,197,1.02 [0.82-1.27],0.8780570720817892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18603,197,1.14 [0.90-1.44],0.2725264946447275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,18163,194,1.15 [0.77-1.72],0.4903955006215346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,16113,168,0.79 [0.54-1.16],0.2300170851633977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,18561,199,1.35 [1.05-1.72],0.0189504594315639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,18209,194,1.13 [0.87-1.47],0.3673198142377822
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,18697,201,1.12 [0.94-1.32],0.2075878423048209
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,18541,199,1.14 [0.92-1.40],0.2358351710926675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15585,161,1.12 [0.84-1.49],0.4519461689275316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,15701,162,1.23 [0.99-1.52],0.0662036527027237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,15833,164,1.02 [0.73-1.42],0.8965451921270463
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,18533,200,1.10 [0.98-1.23],0.1131805032194953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,15754,159,1.06 [0.84-1.34],0.6083871285185565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,18737,201,1.15 [0.79-1.68],0.4601240517210089
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,16084,168,1.32 [0.82-2.11],0.2496700422716173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,15833,164,1.23 [0.89-1.70],0.2121151883073472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,15554,161,1.30 [0.92-1.82],0.1367857069183441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,15554,161,1.02 [0.84-1.23],0.8385872907364257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,18233,194,1.04 [0.88-1.23],0.640830734286234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,18466,193,1.09 [0.94-1.26],0.2683420010803745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18598,197,1.07 [0.91-1.27],0.4115450183656518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,18561,199,1.08 [0.82-1.40],0.5895569186798728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,16029,168,1.20 [0.89-1.63],0.2356346857759191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,16132,167,0.85 [0.49-1.45],0.5397741276525174
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,15701,162,1.19 [0.94-1.50],0.1425395262037128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",15585,161,1.18 [0.83-1.67],0.3490022583635023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",16091,168,1.11 [0.78-1.57],0.5533736155828385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",18163,194,0.75 [0.46-1.24],0.265238707805572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",15516,161,0.79 [0.43-1.46],0.4557428014411212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",16091,168,1.17 [0.98-1.41],0.0803400618921883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",15627,160,0.87 [0.49-1.52],0.6139179061608646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,18435,192,0.91 [0.73-1.14],0.425509933212858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,15701,162,1.22 [0.84-1.77],0.3031084361297746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,18545,201,1.11 [0.93-1.33],0.2421389667875357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,18728,202,1.01 [0.77-1.32],0.9519555398609056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,18603,198,1.07 [0.90-1.28],0.4307188836685603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,15902,164,1.06 [0.84-1.34],0.6151183537425366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,18233,194,1.15 [0.91-1.46],0.2441318494490718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,15627,160,1.11 [0.95-1.30],0.2025079901490706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",16084,168,1.09 [0.62-1.92],0.7707437360506536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15833,164,1.03 [0.90-1.18],0.6592151822497537
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",16059,167,1.03 [0.87-1.21],0.7649520114219613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,18233,194,1.17 [0.82-1.69],0.3858834789587262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,15585,161,0.91 [0.71-1.17],0.4575530219085729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,16059,167,1.06 [0.93-1.21],0.3707034067913523
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,16057,169,1.09 [0.94-1.26],0.2468254541031105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,15833,164,0.88 [0.67-1.17],0.394039566704331
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,18163,194,1.18 [0.92-1.51],0.1886924284818686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,18466,193,1.01 [0.94-1.08],0.8736831209054338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,16119,165,0.93 [0.79-1.09],0.3581280863689375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,15554,161,1.32 [1.01-1.73],0.0406117158135246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,18250,194,0.94 [0.80-1.11],0.4582346079912162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,15754,159,0.85 [0.51-1.40],0.5257395737993682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",16113,168,1.10 [0.91-1.33],0.3105618110817198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",15661,160,1.09 [0.93-1.29],0.2863217324671321
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,16091,168,1.06 [0.85-1.32],0.621181824924687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,16113,168,1.03 [0.89-1.19],0.7064271779893778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,15585,161,0.83 [0.57-1.21],0.3408274762424643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,15554,161,1.14 [0.83-1.57],0.4122430324009628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,16119,165,1.04 [0.91-1.19],0.5497957444736009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15585,161,1.52 [1.14-2.02],0.0040360861650847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,15661,160,1.10 [0.90-1.34],0.35598968970152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,15661,160,1.11 [0.84-1.46],0.4744351153678557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,15701,162,1.07 [0.92-1.24],0.4044124855525589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15701,162,1.17 [0.91-1.50],0.229394010137606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,16091,168,0.92 [0.61-1.38],0.6756619010724728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,18250,194,0.98 [0.81-1.19],0.8416576863668241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,18561,199,1.39 [1.05-1.85],0.0234041604075556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,15625,163,0.90 [0.64-1.28],0.5634885382789032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,15585,161,1.13 [0.87-1.47],0.3596795269098641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,15754,159,1.04 [0.89-1.23],0.5981741894247379
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,18581,198,0.84 [0.65-1.08],0.182113085974842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,18138,192,1.09 [0.85-1.39],0.5066754695267892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,15585,161,1.17 [0.87-1.58],0.2977006570187565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,15701,162,1.09 [0.96-1.23],0.1731430544120088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18325,192,0.99 [0.80-1.23],0.9614986851781672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,16057,169,1.20 [0.94-1.54],0.1358141432195395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,18563,201,1.04 [0.84-1.30],0.6965172205763586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,15599,159,1.13 [0.89-1.43],0.3117420905952928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15633,160,1.21 [0.93-1.58],0.1555349971983325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15754,159,1.29 [0.63-2.64],0.485024366217424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,18138,192,1.09 [0.87-1.36],0.4508517629384324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,16021,167,1.12 [0.78-1.62],0.5354759355158023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,16084,168,1.24 [0.82-1.88],0.3008981162442599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",16091,168,1.20 [0.87-1.65],0.2626241269995416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18603,198,1.33 [0.83-2.13],0.2295491188361962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18250,194,1.11 [0.89-1.37],0.3445478371257486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,18649,198,0.84 [0.57-1.23],0.3657601031546931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,18561,199,1.24 [0.78-1.96],0.3600949065209693
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,18728,202,0.85 [0.61-1.18],0.317637929394812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,18514,197,1.11 [0.97-1.28],0.126450194913368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,18620,198,1.05 [0.93-1.18],0.4336402687125192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,18250,194,1.19 [0.97-1.46],0.0899877474067599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,18528,197,1.06 [0.76-1.49],0.7152182402326162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16059,167,1.29 [0.85-1.97],0.2329625549518846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,18737,201,1.15 [0.74-1.80],0.5346305577142783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,18163,194,0.85 [0.67-1.07],0.1719474668377176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,16057,169,1.07 [0.85-1.34],0.574476587153662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15598,160,1.26 [0.83-1.90],0.2816706382368557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,16059,167,1.06 [0.90-1.25],0.4732289953378438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18138,192,1.14 [0.99-1.31],0.0713837510997378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,15585,161,1.18 [0.82-1.69],0.3685103391076726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,15585,161,1.13 [0.91-1.41],0.2720872608819038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,15627,160,1.11 [0.72-1.71],0.6455961164882936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18543,201,1.32 [0.88-1.98],0.1826826883805303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,18603,198,1.65 [1.15-2.36],0.0066705715340325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15627,160,1.17 [0.84-1.62],0.3533236575528634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,15627,160,1.08 [0.71-1.64],0.7133398351726724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,18111,194,1.03 [0.78-1.36],0.8465412710715228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,15833,164,1.01 [0.82-1.23],0.9438198943034184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,18603,198,0.91 [0.67-1.23],0.5408647696268776
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,18620,198,0.75 [0.48-1.17],0.2060589214451947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,16057,169,1.03 [0.91-1.17],0.6241146666347019
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,16091,168,1.37 [0.78-2.42],0.2725794767242331
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,16132,167,1.08 [0.87-1.33],0.4893633128706296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,18783,201,0.83 [0.53-1.29],0.4082445955717469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,15627,160,1.09 [0.92-1.30],0.3293596657314955
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18553,197,1.09 [0.96-1.24],0.1863915266997632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18250,194,1.02 [0.83-1.26],0.8321058695799671
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,15661,160,1.16 [0.95-1.43],0.1467316583201247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,16091,168,1.18 [0.91-1.52],0.2079664149703801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15585,161,1.17 [0.95-1.43],0.1334535562670265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,15833,164,0.95 [0.71-1.27],0.7076643932007112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18138,192,1.24 [0.96-1.60],0.0997899916629386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",16059,167,1.04 [0.90-1.20],0.5717383074953748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,15585,161,1.12 [0.90-1.40],0.3120064559202569
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15585,161,1.14 [0.81-1.60],0.444099136438672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,18405,192,0.61 [0.21-1.75],0.3569288957083012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,16113,168,0.52 [0.29-0.92],0.0245459966242415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,16084,168,1.54 [0.87-2.71],0.1388810342574127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,15389,159,0.96 [0.58-1.57],0.8617654196931549
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,18595,198,0.84 [0.59-1.19],0.3257487316273971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,18561,199,0.95 [0.80-1.13],0.5501614091395507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,18138,192,1.12 [0.90-1.39],0.2955535118695129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,15661,160,1.23 [0.86-1.75],0.2609132651834063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,16052,167,1.04 [0.84-1.27],0.7366150319918895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,15701,162,1.07 [0.87-1.31],0.5175234461052997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,15625,163,1.01 [0.73-1.40],0.9446525465218916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,15627,160,1.67 [0.88-3.17],0.1157337946144019
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,18559,197,1.08 [0.64-1.84],0.7650628896861635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,15990,168,1.04 [0.85-1.28],0.6804354033384898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18405,192,1.09 [0.94-1.28],0.254262550385311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,15554,161,0.78 [0.50-1.23],0.2819006501825292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,16091,168,1.09 [0.88-1.35],0.414684107543074
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,18561,199,0.72 [0.42-1.24],0.2390995932782506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,15585,161,1.05 [0.93-1.19],0.4479864010944067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",18163,194,1.05 [0.84-1.31],0.6788814608030063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",15585,161,0.74 [0.49-1.12],0.15548334648236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18163,194,0.83 [0.63-1.10],0.1950979623612248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18792,201,1.27 [0.58-2.79],0.5546939632911572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,16119,165,1.09 [0.53-2.21],0.8195857138672816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,18792,201,1.16 [0.79-1.69],0.4494424264636283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15855,162,1.07 [0.65-1.74],0.799302020797981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18563,201,1.29 [0.88-1.88],0.1959643559705192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,15627,160,1.02 [0.65-1.62],0.918498367537062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,15627,160,1.06 [0.92-1.22],0.4269549238324942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,16113,168,0.91 [0.66-1.27],0.5953747835926607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,18233,194,1.12 [1.02-1.23],0.0159253315266314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,18553,197,0.98 [0.76-1.25],0.8598562258180757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,15585,161,1.24 [0.89-1.71],0.2016780077521463
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,18138,192,1.04 [0.89-1.22],0.6281380080293324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,18561,199,0.97 [0.71-1.31],0.8347701514961621
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,16119,165,1.04 [0.66-1.63],0.8711210077729936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,18563,201,0.87 [0.60-1.28],0.4884286155587577
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,18737,201,1.04 [0.85-1.27],0.7088447308721123
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18563,201,0.81 [0.52-1.27],0.3614502900574546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,16132,167,1.03 [0.88-1.22],0.6935520838140714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,16091,168,1.42 [1.09-1.84],0.0088206549128151
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,18683,199,0.90 [0.56-1.43],0.6440207284469373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18561,199,1.04 [0.67-1.62],0.8575722208632874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,18250,194,1.15 [0.90-1.46],0.2659850646308251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,15701,162,1.17 [0.80-1.72],0.4234774365696827
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,18728,202,1.09 [0.90-1.33],0.35985308725504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",16113,168,1.05 [0.86-1.28],0.640546526024877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,16084,168,1.24 [0.79-1.92],0.3465273769289462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,18515,196,1.05 [0.91-1.22],0.4963354520825886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,18603,198,0.81 [0.63-1.04],0.0923467920188139
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,18553,197,0.94 [0.65-1.35],0.7356263718284826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,18138,192,1.07 [0.76-1.50],0.6883868537110512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,18563,201,0.91 [0.56-1.50],0.7199360770728387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,18728,202,1.40 [0.78-2.53],0.2594006272440993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18563,201,1.15 [1.03-1.27],0.0106927890340129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,18553,197,1.07 [0.92-1.24],0.4076570173272809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,16057,169,1.07 [0.94-1.23],0.3001713337074112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,18709,201,1.10 [0.78-1.54],0.5883695589357127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,18783,201,1.12 [0.91-1.36],0.2796854124584074
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15661,160,1.53 [0.98-2.39],0.0602320604456506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15585,161,1.21 [0.95-1.56],0.1289298983368635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,16034,167,1.03 [0.87-1.22],0.7604296288754745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18466,193,1.10 [0.89-1.37],0.3834870882360304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,18561,199,1.16 [0.90-1.48],0.2564454374650286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,15627,160,1.11 [0.92-1.33],0.2818594122155593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,15585,161,1.11 [0.72-1.71],0.6490570583164998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,15585,161,0.98 [0.60-1.60],0.942250323971701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,18163,194,1.03 [0.75-1.42],0.8541708571980461
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,15627,160,0.86 [0.52-1.43],0.5644978799845759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,18347,192,1.07 [0.85-1.34],0.5622214757272674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,16091,168,0.93 [0.65-1.33],0.6807052545471217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,18132,193,1.18 [0.96-1.45],0.1143470065926542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,15833,164,1.15 [0.94-1.40],0.1818654517930748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,16059,167,1.16 [0.94-1.42],0.173088792873426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18466,193,1.19 [0.80-1.77],0.3952813420784442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,18561,199,1.28 [0.96-1.72],0.0983802741666939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15833,164,0.93 [0.73-1.19],0.5842009113901059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,15164,156,0.97 [0.86-1.10],0.6526966898879821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,18381,201,1.07 [0.87-1.32],0.4972468726755372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,18620,198,1.06 [0.77-1.45],0.7373527300144774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,18466,193,1.07 [0.89-1.29],0.442847877449226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,15625,163,1.07 [0.79-1.45],0.6442467432294543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,16084,168,1.13 [0.98-1.29],0.0860717186294326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,15661,160,1.21 [0.98-1.50],0.0743923836001271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,18466,193,1.07 [0.81-1.41],0.627009419233949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,16073,165,0.76 [0.36-1.64],0.4878659458509677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,16084,168,1.18 [0.84-1.64],0.3380213730768122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18559,197,1.06 [0.73-1.53],0.759397156015265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,18460,197,1.05 [0.87-1.27],0.5880834640656909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,18683,199,0.93 [0.48-1.79],0.8193706164041307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,15701,162,1.34 [1.00-1.81],0.0496254275905046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,15625,163,1.08 [0.82-1.42],0.5700820463804139
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,16059,167,1.08 [0.84-1.40],0.5314050594374489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,16091,168,1.09 [0.86-1.38],0.4617294944314782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15661,160,1.16 [0.93-1.43],0.1828105481773665
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,18728,202,1.01 [0.93-1.10],0.8544556232231872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,18460,197,1.17 [0.85-1.62],0.336586502223719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,15585,161,1.17 [0.92-1.49],0.201246114732348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,18250,194,0.99 [0.79-1.23],0.899553947400811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,18132,193,1.11 [0.96-1.29],0.1578008628301336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,18405,192,1.05 [0.93-1.18],0.4358855818152249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,16091,168,1.09 [0.98-1.21],0.1145240624450481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15833,164,1.03 [0.76-1.38],0.8593099196287715
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18233,194,1.07 [0.85-1.34],0.5817411660016847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,15661,160,1.38 [1.01-1.89],0.0448781010795246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15526,160,1.04 [0.78-1.38],0.8026986488930483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,18163,194,1.02 [0.83-1.25],0.8687863377276587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,15627,160,0.94 [0.62-1.43],0.7836465585413908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,15961,166,0.88 [0.55-1.43],0.612359313199077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,16084,168,1.00 [0.66-1.49],0.9818748704131264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,15585,161,1.04 [0.86-1.25],0.6932983733681244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,18711,201,0.76 [0.50-1.16],0.2018048387986266
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,18561,199,0.86 [0.53-1.38],0.5308577703261821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,18250,194,0.99 [0.76-1.31],0.9695056120024436
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,15833,164,1.14 [0.96-1.35],0.1389726434643559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,18561,199,1.18 [0.92-1.50],0.1939855835858231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18553,197,1.05 [0.85-1.29],0.6766455452128034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,15754,159,1.12 [0.81-1.56],0.4953822333964786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,15554,161,1.25 [0.77-2.03],0.3614877232984638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,18163,194,1.09 [0.85-1.40],0.4850825799616517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,16059,167,1.70 [1.14-2.53],0.0090390338027117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,15625,163,1.03 [0.87-1.22],0.74510365440566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15719,159,0.91 [0.65-1.28],0.5925298834809535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,16091,168,1.10 [0.90-1.35],0.3425933204131922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,18718,201,1.66 [0.97-2.83],0.0648633906256199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,16091,168,1.00 [0.56-1.79],0.9961981153172352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,18563,201,0.98 [0.69-1.38],0.9044236708579412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,16059,167,1.12 [0.76-1.66],0.5668570037483522
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,16059,167,1.32 [0.85-2.06],0.221932338299539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,16057,169,1.08 [0.75-1.54],0.6894137315661566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,15554,161,1.12 [0.92-1.37],0.2623450186968207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,16057,169,0.98 [0.71-1.36],0.9042786136684252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,18792,201,1.04 [0.76-1.42],0.816956917091513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,16059,167,1.03 [0.85-1.26],0.736200009967029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,16113,168,1.05 [0.91-1.23],0.4960997770755238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18704,200,1.14 [0.84-1.55],0.4026540699300741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,18466,193,1.52 [1.02-2.24],0.0379946090819297
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,18728,202,1.11 [0.90-1.37],0.3410508236730666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,18563,201,1.07 [0.89-1.29],0.455413592888901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,15554,161,0.93 [0.68-1.27],0.6483188348539424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15554,161,0.91 [0.67-1.25],0.5764250226032719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15585,161,1.08 [0.86-1.37],0.5076299079684315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15754,159,1.17 [1.01-1.36],0.0411316397782096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,18792,201,0.99 [0.83-1.18],0.903852295867574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,18620,198,1.04 [0.90-1.20],0.6172142034083185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,18138,192,1.63 [1.05-2.55],0.0304220521682991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,18563,201,1.17 [0.75-1.83],0.4925114618489159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,18792,201,1.38 [0.96-2.00],0.081825837042075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,15554,161,0.91 [0.62-1.34],0.6222267099538941
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,15754,159,1.33 [0.76-2.35],0.3200860332734618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,16119,165,1.05 [0.83-1.34],0.6823148298020835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,15554,161,1.22 [0.99-1.51],0.0659221874191078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,16091,168,1.07 [0.94-1.21],0.3039859485604046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,18620,198,1.05 [0.95-1.16],0.3139511617136697
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",18138,192,1.26 [1.02-1.56],0.033421153846575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,15701,162,1.05 [0.79-1.39],0.7402447304571088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15554,161,0.99 [0.73-1.35],0.9519244246715768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,15585,161,1.07 [0.83-1.39],0.5884180422489245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15627,160,0.97 [0.68-1.38],0.8527100883061987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,18792,201,1.37 [0.80-2.36],0.2537762029277965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,18561,199,1.13 [0.91-1.40],0.2801062656382718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,18561,199,1.12 [0.74-1.69],0.5923863490153178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,15661,160,1.02 [0.58-1.78],0.9512151611142986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,15754,159,0.97 [0.58-1.62],0.9157982866205262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,16132,167,0.57 [0.32-1.00],0.0519679997582806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,15627,160,1.13 [1.01-1.28],0.0392317317972962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,16012,166,1.05 [0.90-1.23],0.5159492591717348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,18163,194,0.91 [0.72-1.14],0.3993535357708763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,15554,161,1.10 [0.83-1.45],0.5116290044810863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,15701,162,1.01 [0.80-1.27],0.917694823342058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18439,192,1.21 [1.03-1.42],0.0213658724502184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,16132,167,0.82 [0.69-0.98],0.0286299393317554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",16113,168,1.10 [0.84-1.45],0.4828795711588516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,18783,201,1.44 [0.90-2.31],0.1293385865217444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,18702,201,1.20 [0.90-1.60],0.2127057656540616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,15938,165,0.90 [0.54-1.49],0.6774595385569802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,15585,161,1.14 [0.90-1.44],0.2692388705401732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,15701,162,1.07 [0.85-1.35],0.5511612798081226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,15627,160,1.09 [0.96-1.24],0.1993294197747983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,16091,168,1.05 [0.92-1.19],0.4634559485628902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,16059,167,0.92 [0.69-1.22],0.5531622436521998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,15554,161,0.96 [0.81-1.14],0.6608121304255343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18405,192,0.85 [0.56-1.31],0.471938708961326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15754,159,1.19 [0.82-1.73],0.3548449063368368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,16132,167,1.49 [0.81-2.76],0.2037924660963901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PI3,Elafin,18322,198,1.21 [0.97-1.50],0.0874818459298396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",16091,168,1.18 [0.98-1.41],0.0756124031020471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,18332,196,0.90 [0.63-1.29],0.5708220688181747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18553,197,1.05 [0.85-1.28],0.659520717125829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18561,199,1.64 [1.08-2.49],0.0210562147204824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15627,160,1.03 [0.78-1.35],0.8577127634108972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18561,199,0.98 [0.73-1.33],0.9185991975114832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,18563,201,0.93 [0.75-1.15],0.4896257315395518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15754,159,1.04 [0.84-1.30],0.7117711735037032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,15526,160,1.08 [0.90-1.31],0.3962377605899636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,16113,168,1.45 [0.83-2.56],0.1948325593518073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,15585,161,1.02 [0.79-1.32],0.8849608270426311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,18564,197,1.08 [0.89-1.30],0.4520805216971139
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,15833,164,0.96 [0.78-1.18],0.690281982229844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,18405,192,1.00 [0.80-1.25],0.972660540080495
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,18603,198,1.30 [0.82-2.06],0.2638088863124523
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,18767,201,1.26 [0.95-1.67],0.1105808517591855
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",18545,198,1.11 [0.88-1.39],0.3787217754340933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,18620,198,1.06 [0.92-1.22],0.4497095814078453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,18561,199,1.02 [0.69-1.50],0.9263546216430056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,18732,201,1.00 [0.78-1.28],0.9935836034121324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,18561,199,0.82 [0.52-1.30],0.3910556287593315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18416,197,1.34 [0.85-2.13],0.2062350431358884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",16084,168,1.29 [1.00-1.66],0.0542437164293943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15627,160,1.03 [0.72-1.47],0.8613923680242473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",16084,168,1.06 [0.91-1.23],0.4288919983375873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,16084,168,1.17 [0.95-1.45],0.1336143178635608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,15738,162,0.71 [0.35-1.44],0.3463827720126055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,18163,194,1.05 [0.73-1.51],0.7820074572537367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,18563,201,1.17 [0.88-1.56],0.2822998315514318
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,18563,201,1.05 [0.88-1.27],0.5780825526998794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,16056,168,1.11 [0.86-1.44],0.4380934348332643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,18734,201,1.25 [0.89-1.76],0.1958959927265726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,18138,192,1.07 [0.74-1.55],0.7159092293486728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,16084,168,1.55 [1.00-2.41],0.0507515451284866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,18553,197,1.02 [0.87-1.19],0.7948532209595212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,18708,200,0.95 [0.56-1.60],0.8411755501250997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,18500,199,1.01 [0.77-1.31],0.9667897295218932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18487,201,0.98 [0.92-1.05],0.5576831940045482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,15585,161,0.89 [0.72-1.12],0.3249499284998265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,15585,161,1.10 [0.85-1.41],0.4738306315005128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15701,162,1.02 [0.77-1.37],0.8702479995203184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,18135,194,1.09 [0.97-1.24],0.1603579642220036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,16132,167,1.18 [0.95-1.47],0.1420038573336973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,16084,168,1.12 [0.93-1.34],0.2246082433657922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,18529,197,1.00 [0.96-1.04],0.9887413465251254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,15661,160,1.44 [1.15-1.81],0.0014943510800908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15625,163,0.86 [0.60-1.23],0.4141955467760515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18250,194,1.02 [0.91-1.13],0.7447827195283157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,18466,193,1.52 [0.66-3.53],0.3285712958361082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,18603,198,1.19 [0.76-1.86],0.4450502421922681
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15627,160,0.98 [0.69-1.38],0.8901326875621585
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,15627,160,1.20 [0.73-1.98],0.4697619991579272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18466,193,1.28 [0.94-1.73],0.1170033158301791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,15661,160,0.90 [0.72-1.11],0.3233168725116704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,16132,167,0.83 [0.48-1.42],0.4946023348607876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,18233,194,1.03 [0.72-1.48],0.8674496660083053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,18620,198,1.21 [0.76-1.91],0.420787587110647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,16119,165,1.25 [0.84-1.86],0.2738156395214456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,16011,166,1.04 [0.88-1.24],0.6276960124168255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,18728,202,1.07 [0.82-1.40],0.6222412271079272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,18575,201,1.05 [0.92-1.19],0.5050248103184264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,15833,164,1.17 [0.95-1.44],0.1324817839985484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",16119,165,1.08 [0.86-1.35],0.5135825301852782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,15627,160,0.87 [0.53-1.42],0.5762425217724028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,18138,192,1.24 [0.86-1.78],0.25124604059637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,15627,160,1.03 [0.81-1.30],0.8345567140356867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,16113,168,1.13 [0.86-1.49],0.3796793717763269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,18466,193,1.13 [0.91-1.41],0.2538289047731125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,16057,169,1.04 [0.87-1.24],0.6462519587542153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18603,198,1.06 [0.93-1.21],0.4082561139911738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15833,164,1.13 [0.94-1.36],0.2004071837810205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,16091,168,1.08 [0.90-1.30],0.4225113960908847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,16091,168,0.91 [0.62-1.35],0.6534915753825801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,18563,201,1.06 [0.90-1.23],0.4842818814528423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,18783,201,1.15 [1.01-1.31],0.0394837703314811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,16059,167,1.04 [0.92-1.18],0.5364521902757668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,18405,192,0.81 [0.59-1.12],0.200408963750019
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,15701,162,1.05 [0.87-1.27],0.5844731365376059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,18493,197,1.13 [1.00-1.27],0.0480397683921729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18138,192,1.22 [1.03-1.46],0.025164239189939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,15554,161,0.93 [0.51-1.71],0.8214022393536043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,16119,165,1.03 [0.70-1.52],0.8850288431724588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,16057,169,1.02 [0.74-1.40],0.904571603681534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,18674,200,0.91 [0.61-1.35],0.6261015685609352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,18026,186,0.94 [0.81-1.09],0.4264538126792438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,15868,163,1.03 [0.81-1.31],0.8029167086477144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18250,194,0.96 [0.80-1.14],0.6268249807288033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",18783,201,1.17 [0.96-1.42],0.1130392776914263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,18737,201,1.03 [0.84-1.26],0.7778050210047049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,18250,194,1.35 [0.89-2.06],0.160178383635807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,18529,197,1.24 [0.71-2.16],0.45838050326087
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,16119,165,1.25 [0.93-1.67],0.1365769272010985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,16119,165,1.16 [0.86-1.58],0.3308416413603314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18250,194,1.14 [0.90-1.43],0.2683878221478519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15701,162,1.24 [0.80-1.93],0.3333568610469462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18563,201,1.08 [0.93-1.25],0.3317178362478407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,16050,168,1.10 [0.91-1.33],0.3069220299078662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,18250,194,1.17 [0.89-1.53],0.2596827767351857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,15585,161,1.17 [0.86-1.60],0.3079077773566107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,15754,159,1.11 [0.98-1.26],0.0859890699539524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18138,192,1.12 [0.93-1.35],0.2333986946560708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,18728,202,1.03 [0.87-1.22],0.7095387001159428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,16084,168,1.06 [0.77-1.44],0.7332578264855464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,18627,198,1.21 [0.73-1.99],0.4638227190057796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,15585,161,0.81 [0.49-1.35],0.4274743861789374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,18553,197,0.98 [0.76-1.26],0.8586256690985845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,16135,166,1.14 [0.64-2.03],0.6677946196006145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,15642,157,1.04 [0.84-1.29],0.7283291144154883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,15627,160,1.14 [0.83-1.55],0.4179949044071187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15661,160,1.32 [0.88-1.98],0.1837723401821935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,18649,198,1.23 [0.99-1.53],0.0586534251254947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,15627,160,1.31 [0.89-1.92],0.1733217181631265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,18503,201,1.10 [0.80-1.50],0.5715644600673728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,16084,168,1.12 [0.76-1.65],0.5802160840163402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,18478,198,0.76 [0.55-1.04],0.0904409050723969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18163,194,1.07 [0.95-1.20],0.2764210766780338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,18737,201,1.08 [0.65-1.80],0.7630076631665019
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,18108,200,1.10 [0.86-1.41],0.4332025233633435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,15833,164,0.58 [0.32-1.05],0.0727239508369383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,15980,164,0.88 [0.50-1.54],0.6460633654614882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,16059,167,1.19 [0.89-1.61],0.2469725999343924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,16059,167,1.03 [0.98-1.10],0.2595755954224291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,18405,192,1.04 [0.92-1.16],0.5452044404300993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18553,197,1.10 [0.92-1.32],0.2769018014432861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,18138,192,1.01 [0.76-1.34],0.9431477097331996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,15554,161,1.01 [0.62-1.65],0.968393807933554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,16091,168,1.15 [0.87-1.51],0.3351092644075675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,15701,162,1.09 [0.84-1.41],0.5320554020145702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,18466,193,1.09 [0.87-1.36],0.4741379520487565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,18374,191,1.00 [0.70-1.41],0.9882837748801696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,18329,191,1.00 [0.70-1.43],0.9936587388477808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,18553,197,1.06 [0.83-1.35],0.6654064230289578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,15627,160,1.09 [0.84-1.41],0.5163082706409858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,18553,197,0.96 [0.83-1.10],0.5591285309850553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,18138,192,1.03 [0.83-1.27],0.7846775547751106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15195,154,1.16 [1.00-1.35],0.0571247611521415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18163,194,1.28 [0.84-1.94],0.2489797595635527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18452,197,1.12 [0.74-1.69],0.5840122976091484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,15512,158,1.21 [0.92-1.59],0.1740856151897183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,16113,168,0.84 [0.70-1.01],0.0669526150620627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,15701,162,0.93 [0.77-1.12],0.4480255397204388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18553,197,1.06 [0.77-1.46],0.729555840348049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,18163,194,1.22 [0.87-1.71],0.2605980518582528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,18233,194,1.10 [0.85-1.42],0.4710003036204077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,15627,160,0.92 [0.68-1.26],0.6121480273781226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18405,192,1.09 [0.93-1.28],0.2826694346231261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18598,197,1.10 [0.96-1.28],0.1762094074032852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15601,160,1.15 [0.80-1.64],0.4471794061064564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,16113,168,0.76 [0.46-1.25],0.2813812752204028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16119,165,1.14 [0.59-2.22],0.6985824301327624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,18792,201,0.88 [0.57-1.36],0.56835955219953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,16059,167,1.19 [0.89-1.61],0.2420120213442057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,16059,167,1.25 [0.66-2.38],0.4979373305101628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,18521,197,1.37 [0.81-2.30],0.2404704559203376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18344,192,0.99 [0.67-1.47],0.9720963016143834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,16084,168,0.97 [0.65-1.45],0.8818783455059911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,18792,201,1.08 [0.66-1.77],0.7639131866522773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,16113,168,0.99 [0.62-1.61],0.9800136723686742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15754,159,1.21 [0.94-1.57],0.1458068038871416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,18070,194,0.86 [0.68-1.11],0.2454442983937554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,15833,164,0.80 [0.54-1.18],0.2608629156456458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,18553,197,1.03 [0.79-1.33],0.8503629812944336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,18660,199,1.04 [0.93-1.16],0.4822646703428557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,18728,202,1.22 [0.87-1.70],0.2465215186548967
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,16057,169,0.82 [0.60-1.12],0.215942231128234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,18163,194,1.06 [0.83-1.34],0.6525632086733517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,15661,160,1.08 [0.74-1.57],0.6868646443540367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,15585,161,1.05 [0.91-1.22],0.4910806274036644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,16135,166,1.12 [0.73-1.73],0.6031573143625606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,18468,198,1.16 [0.86-1.56],0.3206038412674298
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,18576,200,1.30 [0.81-2.11],0.2788836218123881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,15814,164,1.16 [0.85-1.58],0.3552758515387251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,16113,168,0.93 [0.71-1.23],0.6275109012761841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,16113,168,1.10 [0.95-1.26],0.1960973393884886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,16113,168,1.07 [0.90-1.29],0.4381909443613838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,16057,169,1.09 [0.86-1.38],0.4914809506749653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,15585,161,1.12 [0.89-1.40],0.338171308184808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,18250,194,0.96 [0.82-1.13],0.6400515379582636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,15585,161,0.95 [0.80-1.14],0.6100802684770495
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15625,163,0.99 [0.77-1.28],0.9475732341608704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,16057,169,1.14 [0.87-1.50],0.3369738727948781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,18553,197,1.09 [0.82-1.44],0.5451451867825884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,18163,194,1.03 [0.79-1.33],0.8539999386814439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,15754,159,1.21 [1.00-1.48],0.0543077558137994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,18138,192,1.19 [0.98-1.44],0.0738654005916222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18250,194,1.06 [0.85-1.31],0.6172769294144405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,15701,162,1.09 [0.89-1.33],0.4046881855783021
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,18138,192,1.17 [0.90-1.52],0.2476234987835948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,15833,164,1.09 [0.85-1.40],0.5066144547201239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,15627,160,1.68 [1.10-2.55],0.0159815104053867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,16057,169,1.16 [0.89-1.52],0.2640432214076994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,15661,160,1.05 [0.78-1.40],0.7639164769777975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,15625,163,1.07 [0.68-1.68],0.770868777740311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,18138,192,1.15 [0.90-1.47],0.2567365941830075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,15627,160,1.04 [0.83-1.29],0.7308826925886065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,15833,164,1.17 [0.89-1.53],0.272480122794593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,18138,192,1.00 [0.67-1.49],0.989608420699938
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,18683,199,0.87 [0.66-1.13],0.2882194789897809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,18163,194,1.18 [0.82-1.71],0.3691321212512632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15554,161,0.89 [0.62-1.28],0.5361995421669764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18138,192,1.17 [0.97-1.41],0.1083345026374288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,16091,168,1.16 [0.80-1.68],0.4296131179639417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,18134,191,1.01 [0.78-1.30],0.940849106409136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,16091,168,1.11 [0.92-1.34],0.2974539522050867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15585,161,1.10 [0.80-1.50],0.5577103953251852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,15554,161,1.50 [1.13-2.00],0.0048474149842801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,15701,162,0.98 [0.79-1.22],0.8567244190553143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,18466,193,1.08 [0.92-1.27],0.353080957282584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,18466,193,1.06 [0.84-1.34],0.619444609592434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,16059,167,1.21 [0.97-1.49],0.0866224824499308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,15627,160,0.97 [0.76-1.23],0.794360549494852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,15661,160,1.08 [0.93-1.25],0.3281754377677718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,16057,169,0.98 [0.73-1.33],0.9189152123321244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,18233,194,0.76 [0.52-1.10],0.1472345471877504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15661,160,1.17 [0.58-2.39],0.661483249306043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,16091,168,1.27 [1.03-1.58],0.0281999919026435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18473,197,1.16 [0.90-1.48],0.2559395952928618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,18792,201,1.09 [0.88-1.35],0.4351692419189279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,18792,201,1.00 [0.82-1.23],0.9711169599516836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,16057,169,0.87 [0.59-1.28],0.4886389997738533
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,18559,197,1.20 [0.94-1.53],0.148592524926039
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,15627,160,0.97 [0.69-1.36],0.8589456491182622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18561,199,1.38 [0.91-2.11],0.1298688172375493
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REN,Renin,18563,201,1.00 [0.86-1.16],0.9945333100418892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,15627,160,1.22 [0.85-1.75],0.2790439529898419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,15554,161,0.97 [0.62-1.51],0.888973353690382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18466,193,0.75 [0.53-1.07],0.1092054592089988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RETN,Resistin,18530,201,1.13 [0.85-1.51],0.4118093456552395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",15585,161,0.91 [0.65-1.28],0.5901214419529597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,16057,169,0.84 [0.42-1.71],0.635880900857373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,16091,168,1.12 [0.92-1.36],0.2480783517753881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15833,164,1.09 [0.88-1.35],0.4298228397082829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,18728,202,1.07 [0.72-1.58],0.737996071404156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,18728,202,0.95 [0.60-1.49],0.8090664648111617
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,16091,168,1.08 [0.84-1.38],0.5534560668335686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,18250,194,1.02 [0.84-1.23],0.8740867738204601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,18309,191,1.09 [0.97-1.22],0.1439578676797426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,15627,160,1.05 [0.77-1.42],0.7753458267418777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15754,159,1.11 [0.82-1.51],0.4910630619068101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,18687,200,1.11 [0.90-1.37],0.3101862790598627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,16113,168,1.09 [0.94-1.27],0.2436749736365558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15585,161,1.07 [0.87-1.32],0.5222815405225196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,16091,168,0.90 [0.62-1.31],0.5940476695948176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,15729,158,1.07 [0.80-1.42],0.6551182534569624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,16132,167,1.04 [0.57-1.90],0.8911285764585473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,15661,160,1.01 [0.73-1.40],0.9479648399383096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,18473,200,1.02 [0.91-1.14],0.7228936007840907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,15620,159,0.72 [0.40-1.32],0.2914966347741418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,16025,167,1.00 [0.61-1.63],0.9927470823710272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,16091,168,1.14 [0.87-1.49],0.3580678907305421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18706,200,1.14 [0.71-1.83],0.5819902869582734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15661,160,1.09 [0.66-1.80],0.7349487530346602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,15627,160,0.96 [0.66-1.41],0.8531431890591731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,15627,160,1.15 [0.80-1.66],0.4548913013250526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,15833,164,1.06 [0.86-1.31],0.5609037750416532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,18138,192,1.12 [0.92-1.35],0.256457624858324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,15833,164,0.96 [0.73-1.27],0.7815488061392069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,15661,160,1.27 [1.02-1.59],0.0336913768756516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18559,197,1.02 [0.60-1.75],0.937599287166274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,18728,202,0.88 [0.50-1.54],0.6582117121672315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,15661,160,1.72 [0.74-4.00],0.2077297934834683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18563,201,1.58 [1.06-2.34],0.0235087106667259
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,18466,193,1.04 [0.77-1.40],0.7902718970568876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,15627,160,1.06 [0.66-1.73],0.7981833928751767
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,15833,164,1.11 [0.92-1.35],0.2796843306470971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,15701,162,1.04 [0.72-1.50],0.8506495716223901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15661,160,1.09 [0.74-1.59],0.6700655556805932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,15585,161,1.15 [0.82-1.60],0.430814690595931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,15701,162,1.03 [0.92-1.16],0.5957413155925337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18138,192,0.85 [0.63-1.15],0.3027376771498221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,18138,192,1.07 [0.88-1.30],0.4845749335478156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,15625,163,1.10 [0.94-1.30],0.2249272524208757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,18405,192,1.45 [1.01-2.09],0.0440664968299201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,18737,201,1.46 [0.93-2.27],0.0977046739629219
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,18466,193,1.12 [0.72-1.74],0.6209526490635404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,15585,161,0.86 [0.61-1.20],0.3720272305681561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",16091,168,1.04 [0.88-1.22],0.6501119317641941
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,18737,201,0.87 [0.59-1.27],0.4704080851963129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,18138,192,0.99 [0.87-1.13],0.8889999515842597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,18728,202,1.09 [0.89-1.33],0.4019364148120959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,15585,161,0.81 [0.50-1.31],0.3902099583215697
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,18424,197,1.04 [0.80-1.34],0.7931718575967869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,18287,192,1.12 [0.94-1.33],0.2034547365373328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,15627,160,1.05 [0.67-1.62],0.8375905720043096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,16091,168,0.94 [0.70-1.26],0.6875837376244539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,18132,193,1.01 [0.82-1.25],0.8957358063208343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,16057,169,0.67 [0.42-1.07],0.0919235397321763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,18603,198,1.04 [0.83-1.31],0.709086282222686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,16091,168,1.03 [0.76-1.39],0.8488174858469633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,18233,194,1.05 [0.84-1.31],0.6777767287663816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,16135,166,1.24 [0.86-1.79],0.2587797016871104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,16091,168,1.08 [0.64-1.81],0.775262787492567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,15625,163,1.07 [0.81-1.42],0.626578026526968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,18553,197,1.08 [0.91-1.29],0.361886767789228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,15833,164,1.02 [0.83-1.25],0.8481500867216545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,16062,166,1.09 [0.95-1.25],0.2081143696297928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15585,161,1.18 [0.84-1.65],0.3513239149898323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,15585,161,1.00 [0.73-1.35],0.9807794762671868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,15833,164,0.88 [0.69-1.12],0.286934096224784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,16091,168,1.07 [0.67-1.71],0.7752551000922632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,16089,165,1.23 [0.81-1.87],0.3283965278129761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,18466,193,1.10 [0.95-1.28],0.2008604263174494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,18728,202,0.92 [0.61-1.40],0.7011782888911682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,18163,194,0.94 [0.74-1.20],0.6059234505448468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,18049,186,1.24 [0.81-1.90],0.3133659653401122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,18792,201,1.09 [0.81-1.47],0.5507774254768497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,18728,202,1.21 [0.78-1.90],0.3936609029948759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,18659,200,1.33 [0.91-1.95],0.1431143854209325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,18559,197,1.00 [0.68-1.45],0.9834758148700384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,18567,198,0.99 [0.78-1.26],0.9567813513327836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,15585,161,0.90 [0.53-1.52],0.6870316498226762
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,15754,159,1.38 [0.77-2.49],0.2803465722179504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,18598,197,0.93 [0.79-1.10],0.39691351238614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,18250,194,1.21 [0.91-1.61],0.1944593959353069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,15625,163,1.00 [0.82-1.23],0.9895711786484565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,18687,200,0.92 [0.70-1.21],0.5383448474115371
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,15625,163,0.99 [0.73-1.36],0.9728276959054868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,15701,162,1.21 [0.71-2.05],0.4782670155009095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,15701,162,1.15 [0.79-1.69],0.459088671635727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,15625,163,1.19 [0.90-1.58],0.2136315417196461
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,15661,160,1.11 [0.77-1.60],0.5812621351778159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,18138,192,1.00 [0.84-1.18],0.9758427765084456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,15609,158,1.21 [0.90-1.63],0.2119857744335744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,16113,168,0.89 [0.51-1.57],0.6885199084186395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,15661,160,1.03 [0.88-1.22],0.6878848027269002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,18553,197,1.02 [0.81-1.28],0.8862876650448924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCT,Secretin,15701,162,1.01 [0.73-1.39],0.952815275178242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,18563,201,1.20 [0.88-1.64],0.2432442537568177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18563,201,1.08 [0.82-1.42],0.5721625062156449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,16057,169,1.10 [0.97-1.25],0.1474503118988109
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,16059,167,1.09 [0.87-1.37],0.4529565968812126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15754,159,1.00 [0.66-1.50],0.9892860988322818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,15661,160,1.22 [1.00-1.50],0.0521155021034409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,15661,160,0.96 [0.57-1.63],0.8870029046136539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,18792,201,1.26 [0.98-1.62],0.0678769541589846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,16135,166,1.12 [0.59-2.15],0.7244648909160147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16135,166,1.62 [0.84-3.12],0.15335211758158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,18649,198,0.97 [0.77-1.21],0.7586135686250014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18553,197,0.71 [0.45-1.13],0.1498334232324653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18563,201,0.75 [0.46-1.21],0.2370994427812644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15754,159,1.15 [0.83-1.61],0.3991234058920726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,18466,193,1.46 [1.02-2.08],0.0383208135019015
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,18728,202,0.99 [0.66-1.49],0.9642103937220512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,15627,160,1.18 [0.68-2.03],0.5618444276248213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18732,201,0.97 [0.61-1.55],0.9010009551596426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,16091,168,0.95 [0.78-1.16],0.6222129671392556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,15833,164,1.02 [0.77-1.35],0.8801127013030197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,16051,167,1.29 [0.84-2.00],0.2472137201107951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18466,193,1.29 [0.87-1.92],0.2109388029387618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,15840,164,0.70 [0.11-4.69],0.7147223875306792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,18792,201,1.05 [0.78-1.42],0.7438130245373532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,18040,193,1.02 [0.90-1.16],0.7410417558508386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,16092,166,0.91 [0.33-2.46],0.8482477768247048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,15846,165,1.34 [0.71-2.52],0.3698810452875735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,15900,166,1.50 [1.04-2.19],0.0319842995200927
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,16135,166,0.65 [0.25-1.71],0.3853156694087982
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,16135,166,0.64 [0.28-1.43],0.273813190157628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,18388,193,0.95 [0.79-1.15],0.6267216675486857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,18505,198,1.09 [0.95-1.25],0.2202943862938372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,18233,194,1.24 [0.95-1.63],0.1149009602624567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,18665,201,1.12 [0.91-1.38],0.2998569281735856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18783,201,1.03 [0.84-1.26],0.7998659351132404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,18405,192,1.20 [0.81-1.79],0.3586930356896464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,16110,166,1.58 [0.58-4.34],0.373975617666631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,16110,166,0.85 [0.51-1.43],0.5498842231059302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,18792,201,0.98 [0.81-1.17],0.7920195454935459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,16113,168,0.99 [0.79-1.25],0.9489560496300224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,15897,164,0.82 [0.46-1.46],0.4976362426879684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,15829,163,0.77 [0.25-2.38],0.6458226851421511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,16110,166,0.62 [0.28-1.41],0.2548502513367227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,15833,164,1.06 [0.95-1.20],0.3054697756496431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,15727,159,1.26 [0.74-2.13],0.3892325027009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,16059,167,1.24 [0.97-1.60],0.0905332001864901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18163,194,1.06 [0.87-1.29],0.5630533045043284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18338,192,0.84 [0.54-1.30],0.434354079528494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,15701,162,1.54 [1.00-2.39],0.0510142414853469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,18603,198,1.07 [0.68-1.70],0.7705221764996696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,18466,193,1.41 [0.84-2.37],0.1940744633372349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,18466,193,0.97 [0.82-1.15],0.7351967292970241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,18338,192,0.99 [0.73-1.35],0.9543465950807564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,15754,159,0.71 [0.48-1.05],0.0888667748518327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,18138,192,1.03 [0.81-1.29],0.8324036964540933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,18138,192,1.10 [0.86-1.42],0.4332107796878401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,18563,201,0.82 [0.68-0.99],0.0423219116692708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,15861,164,1.03 [0.79-1.34],0.8453815581859396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,18138,192,1.14 [1.00-1.30],0.049726275864876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,18553,197,1.06 [0.86-1.30],0.5930447677136933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15625,163,1.14 [0.92-1.41],0.2172703631039085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,16059,167,1.02 [0.77-1.36],0.8844716970394652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,15737,163,1.04 [0.87-1.25],0.6305023523484907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,16084,168,1.19 [0.96-1.48],0.1136884398950975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,16132,167,0.99 [0.72-1.37],0.9708483952496229
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,15554,161,1.04 [0.91-1.18],0.5917713584682518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,15556,160,0.99 [0.82-1.19],0.9054880627167186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,15627,160,1.15 [0.82-1.61],0.41572935472392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16119,165,1.25 [0.70-2.24],0.455004008332482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",18598,197,0.98 [0.84-1.14],0.7564011701491328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,15833,164,1.06 [0.74-1.52],0.7472509423302472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,18574,198,1.07 [0.82-1.41],0.6191585976509314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18620,198,1.02 [0.75-1.39],0.8896717687058868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18553,197,1.04 [0.71-1.54],0.8316066624418015
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,18163,194,1.14 [0.98-1.33],0.0809823738308773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18561,199,0.97 [0.87-1.08],0.561404865319483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18737,201,1.58 [1.08-2.30],0.0176260395530134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,18563,201,0.80 [0.51-1.27],0.3500145092682548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15661,160,1.34 [0.96-1.88],0.0893326599979189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18710,200,1.35 [0.88-2.05],0.1650851953733296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,15661,160,1.34 [0.95-1.91],0.098207213740122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18610,200,0.94 [0.76-1.16],0.5576429622260877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,18495,197,1.09 [0.84-1.43],0.5168247216784223
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,15627,160,1.06 [0.91-1.25],0.4411209281907263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,18466,193,1.10 [0.95-1.28],0.1865894738358572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18163,194,1.09 [0.87-1.37],0.4492156435564179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18250,194,1.08 [0.86-1.37],0.5120517673450875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,18377,192,1.06 [0.89-1.26],0.5176581619456848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,18620,198,1.04 [0.92-1.17],0.5435242758222092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,15585,161,0.92 [0.61-1.39],0.6850489881327243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,16091,168,1.06 [0.92-1.22],0.4430896056041316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,18250,194,0.97 [0.78-1.21],0.8071923502314067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18138,192,1.20 [0.85-1.69],0.2921682052138446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,18553,197,0.80 [0.64-1.00],0.0454158009597159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,18138,192,1.09 [0.85-1.39],0.5156747393574472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,15585,161,0.89 [0.50-1.60],0.6932228641017422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,16057,169,0.94 [0.71-1.23],0.6309627237448518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,18163,194,1.06 [0.85-1.33],0.6031262411337844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,15701,162,1.08 [0.82-1.42],0.5935980817879375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,18163,194,0.99 [0.81-1.20],0.92150601632944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,15554,161,0.99 [0.76-1.28],0.9341595731700942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,15554,161,1.25 [0.95-1.64],0.1109798018482123
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,18163,194,0.92 [0.62-1.36],0.672605784409749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,18553,197,1.07 [0.84-1.37],0.5704438422085194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,15701,162,1.13 [0.93-1.38],0.2126805671685179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,16119,165,1.00 [0.74-1.36],0.9826025289155684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,15585,161,0.96 [0.77-1.19],0.6969850261241604
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15754,159,1.15 [0.96-1.37],0.1276719012604208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,16059,167,1.08 [0.82-1.41],0.5932441592825843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15554,161,0.98 [0.74-1.28],0.8632268891614858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,18163,194,1.07 [0.85-1.35],0.568234595942507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,15627,160,1.02 [0.63-1.63],0.9450726904893688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18737,201,1.10 [0.81-1.50],0.5505929746478191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,18233,194,1.28 [0.89-1.83],0.1793168363351397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,15833,164,0.93 [0.75-1.15],0.4895705906841917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,16059,167,1.05 [0.88-1.25],0.6177437800551013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,16006,165,1.29 [0.89-1.86],0.1840337390340355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,18138,192,1.08 [0.93-1.26],0.2988977641348681
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,16057,169,1.06 [0.86-1.30],0.600672386014607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,16057,169,1.18 [0.90-1.56],0.2244871850083587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,18466,193,1.52 [0.79-2.96],0.2126035561672513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,18163,194,1.04 [0.87-1.23],0.6791314644700177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,15554,161,1.21 [0.95-1.56],0.124970559895069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,16059,167,1.17 [0.95-1.43],0.1406471473621362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,18737,201,0.93 [0.63-1.38],0.7291529067696254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,18620,198,0.89 [0.63-1.24],0.4765547554320417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,18634,201,1.15 [0.90-1.46],0.2610448725485652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,15627,160,1.10 [0.87-1.40],0.4212716700920212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18586,198,1.17 [0.96-1.42],0.1112166117991715
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,16057,169,1.05 [0.88-1.26],0.5940833790902238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,15625,163,1.05 [0.84-1.32],0.6502716687943568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,16051,167,1.11 [0.94-1.29],0.2119221636719064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,18563,201,1.07 [0.92-1.23],0.388504098099072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,15625,163,0.93 [0.68-1.28],0.6680557583373429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,18603,198,1.03 [0.90-1.19],0.6410011123598369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,16091,168,1.16 [0.91-1.49],0.230162511458008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,15754,159,1.10 [0.97-1.26],0.145674431975412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,18405,192,1.20 [0.98-1.46],0.0753392146462368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15661,160,1.51 [1.01-2.27],0.0472564627821981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',16084,168,1.13 [0.87-1.46],0.3773729994551431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15585,161,1.17 [0.96-1.44],0.1248633737909296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,15754,159,1.28 [0.98-1.69],0.0748625858775716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,16059,167,1.15 [0.84-1.57],0.385221210874465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,16057,169,1.09 [0.93-1.28],0.2886178788844216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,15661,160,1.41 [0.89-2.24],0.1451366833633272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,18563,201,1.03 [0.86-1.24],0.7448784408898668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],18213,191,1.04 [0.80-1.36],0.7602631599658547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",18561,199,1.01 [0.72-1.42],0.9440570556929782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,16132,167,1.02 [0.80-1.29],0.8999230733558253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,16091,168,1.27 [0.95-1.70],0.1124785283849322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,18138,192,1.27 [0.88-1.84],0.2051739746239061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,18654,200,1.00 [0.83-1.20],0.9724626785862324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,18543,201,1.02 [0.74-1.43],0.8864811892383561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,18543,201,1.30 [0.94-1.80],0.1064898941491073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15701,162,0.97 [0.70-1.33],0.8337460248413076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,16053,168,0.56 [0.29-1.09],0.085988957205799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,15701,162,1.12 [0.64-1.98],0.6914896974465232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,16091,168,0.79 [0.47-1.35],0.3881210252139281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,16091,168,1.00 [0.78-1.29],0.9809631143768336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,18603,198,1.00 [0.84-1.19],0.963091786691972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,18584,197,1.13 [0.74-1.73],0.5801019638696306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPART,Spartin,15754,159,1.18 [0.97-1.44],0.0902633140531681
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,16113,168,0.90 [0.58-1.39],0.6229298274635401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,18561,199,1.45 [1.08-1.95],0.0140267230552725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,15754,159,0.94 [0.60-1.48],0.7920982141269124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,18553,197,1.08 [0.89-1.31],0.4236850999381337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,18561,199,1.20 [0.84-1.71],0.3253786257389755
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,18737,201,1.00 [0.79-1.27],0.989979832364949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,15585,161,1.14 [0.77-1.69],0.5114069780896392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18494,198,0.82 [0.49-1.37],0.4476994160495847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,18620,198,1.21 [0.88-1.67],0.2409922373614913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,16059,167,1.04 [0.95-1.14],0.4154031110615143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,18405,192,0.66 [0.40-1.09],0.1073878501325308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,18559,197,1.02 [0.69-1.52],0.9048768806562442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,18481,200,0.99 [0.68-1.44],0.95566015918504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,18762,201,1.20 [0.90-1.60],0.2251968634130151
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15627,160,1.33 [0.97-1.82],0.0741346905700325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,15554,161,1.15 [0.93-1.41],0.1906932185970507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,15833,164,1.02 [0.86-1.21],0.8134478899652644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,16084,168,0.76 [0.60-0.97],0.0272366497582681
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,18250,194,1.07 [0.93-1.23],0.3466196117304877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15625,163,0.69 [0.41-1.16],0.1659424706364517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,16084,168,1.00 [0.69-1.47],0.9811626686158816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,18573,197,1.07 [0.97-1.20],0.1835587048199038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18466,193,1.17 [0.95-1.43],0.1372443148946606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,18553,197,1.06 [0.92-1.23],0.4334021066759489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,16113,168,1.28 [0.87-1.90],0.2137255264166239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,18163,194,1.02 [0.83-1.26],0.8406105359874594
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15627,160,1.38 [0.97-1.95],0.0745005413699727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18543,201,1.03 [0.93-1.14],0.6058648502430566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18649,198,1.08 [0.80-1.45],0.6146617086409367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,15554,161,1.05 [0.63-1.76],0.8488563903905858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,16059,167,0.94 [0.70-1.27],0.69922516024292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,15754,159,1.20 [0.91-1.59],0.1900668933427192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18466,193,1.22 [0.94-1.59],0.1395366233681304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18792,201,0.78 [0.51-1.20],0.2655748736511429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15627,160,0.94 [0.69-1.30],0.7153350929029967
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,16119,165,0.65 [0.39-1.09],0.1028161320858955
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,16057,169,1.28 [0.89-1.84],0.181335478024228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,18377,192,1.05 [0.85-1.28],0.6546262696597875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,15627,160,1.04 [0.86-1.27],0.6775090847877655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,18466,193,1.06 [0.96-1.16],0.2561780643710956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15554,161,1.10 [0.89-1.36],0.3785421555385886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18728,202,1.03 [0.78-1.36],0.8273249797801597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,18538,198,1.25 [0.73-2.14],0.4219674452253846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,15625,163,1.07 [0.88-1.30],0.510775634012604
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,18525,198,1.11 [0.91-1.34],0.2940564662237199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,18233,194,1.04 [0.87-1.25],0.6412396548951595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,18163,194,1.06 [0.86-1.30],0.6029032523779645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,18563,201,1.06 [0.92-1.22],0.4278982525183668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",15554,161,1.02 [0.88-1.20],0.7675440894980744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,18138,192,1.07 [0.87-1.33],0.5074811611090482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,15701,162,1.11 [0.79-1.56],0.5559607694222168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,16084,168,1.33 [0.98-1.81],0.0653290141413139
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,18466,193,1.04 [0.84-1.28],0.7277927781159161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,15627,160,1.24 [0.89-1.71],0.1994373392275372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,18138,192,1.14 [0.95-1.37],0.1514584643467557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,15627,160,1.05 [0.77-1.43],0.7664987641920338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,18553,197,1.18 [0.91-1.52],0.2129156395510082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,16091,168,1.12 [0.92-1.35],0.2632521923674328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,18138,192,1.16 [0.88-1.53],0.3034591182467208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,16059,167,1.23 [0.87-1.75],0.2369383223254964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,18138,192,1.12 [0.95-1.32],0.160151524690438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,18728,202,1.08 [0.98-1.19],0.1433678803148512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,18553,197,1.02 [0.82-1.26],0.8903920755923646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,15627,160,1.13 [0.92-1.39],0.2271200439522233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18728,202,1.07 [0.84-1.36],0.5872016982839559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",16091,168,1.09 [0.87-1.37],0.468537350954779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,18233,194,0.97 [0.74-1.26],0.8082419972160364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,18561,199,1.30 [0.84-2.00],0.2368105599298148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,16057,169,0.86 [0.58-1.27],0.4559811873875692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,15683,159,1.16 [0.73-1.82],0.5346928603324237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,15701,162,1.04 [0.82-1.32],0.7689905242630612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,16059,167,1.08 [0.72-1.61],0.7098529388332635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,15754,159,1.21 [0.94-1.56],0.1470162799746651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15625,163,1.06 [0.82-1.36],0.6565060944694345
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,16084,168,0.92 [0.62-1.35],0.6667742892114291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,16113,168,1.11 [0.91-1.35],0.2937878824914899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15833,164,1.14 [0.99-1.31],0.0793952118856717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,18466,193,1.04 [0.93-1.16],0.5270428443496877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,16438,164,1.49 [0.91-2.43],0.1096770036171427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,16057,169,1.03 [0.71-1.48],0.8808635522569238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,18466,193,1.34 [0.95-1.91],0.0994733698040581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,15554,161,1.18 [0.94-1.48],0.1578983796193037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,16071,165,1.06 [0.76-1.49],0.7335759614278463
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,18250,194,1.25 [1.05-1.48],0.0125879446518416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,15833,164,0.93 [0.70-1.24],0.6259995764326696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,18163,194,1.13 [0.96-1.33],0.1424176792993702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15701,162,1.05 [0.87-1.27],0.6242648385867262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",16057,169,1.21 [0.84-1.74],0.3127518554151374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,16084,168,1.19 [0.95-1.49],0.1373589823998886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,18163,194,1.21 [0.92-1.59],0.1729154685903186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,18466,193,1.06 [0.92-1.22],0.4252151230951809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,18553,197,1.03 [0.88-1.21],0.6790070598068387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,15754,159,1.10 [0.92-1.32],0.3129679920743833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,18405,192,1.07 [0.94-1.22],0.3099645381925976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,18405,192,1.11 [0.95-1.30],0.2032279936041543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,18138,192,1.10 [0.94-1.27],0.2411438157029636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,15701,162,0.94 [0.67-1.32],0.7312679416870871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18382,192,1.01 [0.89-1.15],0.8219290998978923
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,18233,194,0.95 [0.80-1.13],0.5848628403537288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,15815,165,1.13 [0.75-1.71],0.5545273611538877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,18762,201,0.80 [0.52-1.22],0.2957877007514123
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16113,168,1.06 [0.67-1.68],0.8083163846049921
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,15833,164,0.97 [0.74-1.28],0.8450896845536195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,16113,168,0.96 [0.59-1.56],0.8654499460920965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,18163,194,1.03 [0.94-1.12],0.5479326160135529
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",15701,162,1.11 [0.76-1.62],0.5979064839704162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,16057,169,1.18 [1.00-1.40],0.04922468790511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,18163,194,1.14 [0.98-1.32],0.079189559171426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,15585,161,0.85 [0.59-1.24],0.4059803562913795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,18603,198,1.39 [0.79-2.44],0.2481802124040808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,15627,160,1.38 [0.85-2.25],0.1955244926830009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,15804,164,1.02 [0.88-1.17],0.8199490919158237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,15701,162,0.98 [0.77-1.26],0.8771088061260894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,15833,164,0.54 [0.32-0.91],0.0195626702675293
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,16135,166,0.81 [0.41-1.61],0.5412245301956609
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,15625,163,0.95 [0.73-1.22],0.6757222603375455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,18484,198,1.15 [0.99-1.34],0.0610166921508055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,18598,197,0.96 [0.76-1.20],0.6945174796357698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18566,197,1.14 [0.81-1.61],0.4569250928189903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,18536,198,0.90 [0.60-1.37],0.6374339273632723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,18549,198,1.00 [0.72-1.40],0.9872497660824304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18650,198,1.20 [0.87-1.67],0.2720436034697389
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,16057,169,0.95 [0.82-1.10],0.508031340755005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,18553,197,1.27 [0.97-1.66],0.0835739784339427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,18750,201,1.16 [0.85-1.59],0.3415324702227871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,16057,169,1.10 [0.84-1.44],0.4988736938977119
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,18479,198,0.61 [0.38-0.98],0.0429874515768873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,15627,160,1.93 [1.25-2.97],0.002862783412949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18603,198,1.40 [0.97-2.01],0.070470964790253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,18792,201,1.88 [1.25-2.85],0.0026290260903538
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18530,200,1.02 [0.86-1.21],0.8118059712258099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,16132,167,0.96 [0.55-1.70],0.8998063766357018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,15526,160,0.94 [0.78-1.14],0.5299329422655571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18563,201,0.97 [0.62-1.49],0.872517716859797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,18561,199,1.03 [0.74-1.45],0.8456476710909916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,18595,198,0.98 [0.74-1.30],0.8873639244223005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,18479,200,0.81 [0.53-1.22],0.3067042287975173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,18233,194,1.03 [0.74-1.43],0.8655128310475206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,15585,161,1.10 [0.97-1.24],0.1530806113422998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,15507,158,1.28 [0.84-1.96],0.2462150414404183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,16018,169,1.05 [0.88-1.24],0.6034557672550172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18728,202,1.22 [0.79-1.89],0.3678592829006729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,18028,192,1.02 [0.92-1.13],0.7319439591127943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,18792,201,0.94 [0.71-1.26],0.6932589625448591
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18135,194,0.92 [0.69-1.22],0.5514536394001357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15833,164,1.02 [0.69-1.51],0.9043409110448656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18649,198,1.20 [0.89-1.61],0.2351287009599512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,16113,168,0.98 [0.68-1.43],0.9322321614348772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,16084,168,1.10 [0.92-1.30],0.293091922883289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,18391,196,0.80 [0.50-1.27],0.3427839374007224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,16113,168,0.73 [0.38-1.38],0.3316780569529304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,18620,198,0.94 [0.85-1.04],0.2274467463944335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,18561,199,1.20 [0.88-1.64],0.2549515800043285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18513,200,1.00 [0.56-1.78],0.994402053762698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,18603,198,1.10 [0.95-1.28],0.2120021505581343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,15625,163,1.07 [0.75-1.52],0.7090481835967395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",15833,164,1.09 [0.79-1.50],0.59849107514972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,15627,160,1.16 [0.66-2.05],0.6071053785493801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,15833,164,0.84 [0.44-1.60],0.5859019101295047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,18783,201,1.00 [0.82-1.22],0.9995770657190084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,15627,160,1.54 [0.92-2.58],0.1007496353659651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15701,162,1.00 [0.76-1.32],0.992381300516178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,15833,164,0.99 [0.76-1.30],0.951702778389566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,15585,161,1.02 [0.74-1.40],0.926000842500706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,15585,161,1.19 [0.94-1.49],0.1429319517660788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,16059,167,1.08 [0.93-1.24],0.3223807653753372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,16057,169,1.15 [0.94-1.40],0.1640761050002881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,15661,160,1.40 [1.12-1.75],0.0034028179634561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,16091,168,1.01 [0.74-1.39],0.938525924262964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,15554,161,1.01 [0.69-1.49],0.9504560717256112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,15625,163,1.00 [0.82-1.22],0.965245062373382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,16051,167,0.96 [0.64-1.42],0.8327363777975818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,18466,193,1.13 [0.98-1.30],0.1026813711863833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,18316,191,0.94 [0.67-1.32],0.7289542374269316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,18561,199,1.09 [0.93-1.29],0.2859889077333071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,18649,198,1.00 [0.77-1.30],0.9917413816404468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18208,194,1.07 [0.75-1.54],0.6962375718378324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,16059,167,1.05 [0.78-1.42],0.7249625216945188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18250,194,1.02 [0.72-1.44],0.9181690457318764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15754,159,1.25 [0.99-1.58],0.0578792958811898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18405,192,0.93 [0.62-1.39],0.7184034030927764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18405,192,1.17 [0.94-1.47],0.1655975154322702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18606,201,1.09 [0.84-1.41],0.5028001343864166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18783,201,1.51 [1.11-2.05],0.0084711423294043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18529,197,1.02 [0.66-1.58],0.9196271191279216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18603,198,1.05 [0.74-1.50],0.7750417784518638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18559,197,0.89 [0.59-1.33],0.5611039934779205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18250,194,1.40 [1.03-1.92],0.0330411273565801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18559,197,1.38 [0.92-2.06],0.1172341615407179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15754,159,0.90 [0.62-1.32],0.5951582909113309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18737,201,1.49 [1.03-2.15],0.0348467738248225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18561,199,1.37 [0.91-2.06],0.1319050836529701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18561,199,1.13 [0.81-1.58],0.460714280662999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18728,202,1.45 [0.93-2.27],0.0994619663761981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18750,201,0.98 [0.69-1.38],0.8959234524390004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18405,192,1.14 [0.92-1.43],0.2327314587557211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18728,202,1.02 [0.76-1.35],0.9178919523423092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18405,192,1.22 [0.89-1.68],0.2142325091869837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18783,201,0.94 [0.57-1.54],0.8018916329129384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18553,197,0.93 [0.75-1.14],0.4710989366998368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,18783,201,1.23 [0.79-1.91],0.3567749688084716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18620,198,1.67 [1.05-2.65],0.0309439520220429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18761,201,1.01 [0.63-1.62],0.9588269450215976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,18405,192,1.05 [0.84-1.31],0.649482540730608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16119,165,1.42 [0.96-2.11],0.079910266504502
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,16084,168,1.13 [0.96-1.33],0.1369845309353581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,16119,165,1.26 [0.89-1.77],0.1935629639625428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",18233,194,1.10 [0.94-1.29],0.2427468214010541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,15833,164,0.67 [0.44-1.04],0.0770126471678092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,18405,192,1.18 [0.87-1.60],0.2834317558567985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,18561,199,1.09 [0.67-1.78],0.7248924522421839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,16113,168,0.98 [0.81-1.19],0.8325522769199463
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,16059,167,0.99 [0.87-1.12],0.853666952983879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",15554,161,0.92 [0.66-1.29],0.6381397558877775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15627,160,1.10 [0.91-1.33],0.3349037447173867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,15661,160,1.08 [0.83-1.42],0.5515353299818223
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,18138,192,1.25 [0.94-1.65],0.1202300524462714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15627,160,1.10 [0.92-1.30],0.2922858203311019
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,15413,158,1.06 [0.79-1.43],0.6804775230196813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,18233,194,1.44 [1.05-1.98],0.0231687988868605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,15701,162,1.05 [0.67-1.64],0.8268778690584846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,15701,162,1.36 [1.02-1.82],0.0361793957319741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,15754,159,1.09 [0.94-1.26],0.2346734911495867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,16113,168,0.83 [0.49-1.42],0.5014175463961905
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,15585,161,0.94 [0.67-1.32],0.715820870538144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,18138,192,1.09 [0.92-1.30],0.30936379296458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,18412,196,1.00 [0.76-1.33],0.9796051578340624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,15833,164,1.04 [0.86-1.25],0.6741530751496012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,18163,194,0.83 [0.57-1.19],0.302673895689575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15585,161,1.12 [0.86-1.45],0.4136195508895322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,15554,161,1.07 [0.87-1.32],0.5255239290190378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,18757,201,1.01 [0.79-1.28],0.9552141473756806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,16091,168,0.86 [0.56-1.31],0.4717610617738447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,15627,160,1.83 [1.19-2.81],0.0055600980691937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,18250,194,1.00 [0.83-1.21],0.9686084867859486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,18553,197,1.10 [0.92-1.32],0.2879550531369924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15627,160,1.35 [0.98-1.88],0.0689972617546437
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15585,161,1.07 [0.79-1.44],0.67421144991333
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15833,164,1.14 [0.97-1.34],0.1095655901839271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,16119,165,1.05 [0.86-1.28],0.641574627044627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,18529,197,0.99 [0.78-1.26],0.9308716484628956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,16132,167,0.99 [0.75-1.32],0.9653430801771988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18561,199,1.15 [0.79-1.66],0.4614381496788544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,18737,201,1.12 [0.92-1.36],0.2679470675140515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,18553,197,0.97 [0.81-1.15],0.6956335907769802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,15805,163,1.06 [0.84-1.33],0.6281949894349952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,16059,167,1.11 [0.96-1.27],0.1524034678689356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,15554,161,0.99 [0.75-1.30],0.9284236670054532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,15701,162,0.99 [0.80-1.22],0.9209498810746184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,18553,197,1.07 [0.93-1.24],0.3571093377382428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,16057,169,1.12 [0.95-1.33],0.1781736735769103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,15585,161,1.29 [1.01-1.64],0.042183009644699
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,15627,160,1.16 [0.98-1.38],0.0840488709190735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,16091,168,1.13 [0.91-1.41],0.272025691566082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,18563,201,1.05 [0.88-1.26],0.5767428677860051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,18233,194,1.15 [0.95-1.39],0.1446367071980227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,15585,161,1.17 [0.81-1.70],0.4019199869745726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,18233,194,1.07 [0.93-1.24],0.3470706924816163
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,15585,161,0.96 [0.70-1.31],0.781161268033784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,15625,163,1.10 [0.96-1.27],0.1761137098799929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,16059,167,0.97 [0.83-1.14],0.748246234595237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,15627,160,1.09 [0.75-1.58],0.6594250104337296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,18134,194,1.00 [0.84-1.19],0.988682653233981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,15701,162,1.14 [0.85-1.53],0.3916466682985047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTN,Titin,15585,161,1.06 [0.87-1.31],0.5522889606109942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,15971,165,1.46 [0.79-2.71],0.2309133008199296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,15625,163,1.01 [0.60-1.71],0.9668471364293144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,16119,165,1.07 [0.90-1.27],0.4538197911412358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,15833,164,1.06 [0.88-1.27],0.5678590250710711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,18405,192,1.09 [0.94-1.26],0.2715664059382346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,15874,164,1.16 [0.83-1.61],0.3887565030295872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,18603,198,0.89 [0.56-1.41],0.6240314623084637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,18728,202,1.06 [0.89-1.27],0.5216817883712008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,16084,168,1.26 [0.98-1.63],0.07601218886181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,15598,163,1.08 [0.94-1.23],0.2708467034167431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18561,199,1.08 [0.82-1.41],0.5951251108125709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,18447,198,0.95 [0.79-1.16],0.6243240414666067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,18563,201,1.17 [0.75-1.81],0.4955971586750696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15627,160,1.18 [0.92-1.51],0.1954046684885689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,18466,193,1.34 [0.92-1.95],0.1280341275754808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,16057,169,1.18 [0.73-1.90],0.5107726122689832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,16113,168,1.00 [0.78-1.27],0.979679333080422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15627,160,0.97 [0.74-1.27],0.8149265322734659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,15585,161,0.88 [0.66-1.19],0.420428319213781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,15754,159,1.15 [0.92-1.43],0.2191136198387107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,16059,167,1.04 [0.93-1.15],0.5247125856828958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,15585,161,1.11 [0.97-1.26],0.1277873179078775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,15585,161,0.98 [0.63-1.53],0.9239509770438123
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18405,192,1.40 [1.01-1.94],0.0412261420341205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,18728,201,0.88 [0.70-1.11],0.2906842718287659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,15627,160,1.51 [0.89-2.58],0.1285541170967709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,15554,161,1.13 [0.87-1.47],0.3630284547835235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,16057,169,1.04 [0.69-1.56],0.8639752115708695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,16113,168,0.98 [0.83-1.17],0.8599878783106516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,15625,163,0.99 [0.73-1.34],0.9319694396371369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,15795,164,1.06 [0.81-1.39],0.6876259397031159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,15754,159,1.11 [0.89-1.40],0.3519297889931174
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,15701,162,1.04 [0.83-1.30],0.7550737442807941
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,18466,193,1.07 [0.92-1.23],0.3890681296398982
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,16057,169,1.11 [0.90-1.36],0.3362189591227208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,16084,168,1.27 [0.89-1.82],0.1834728421052036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,15585,161,1.03 [0.87-1.22],0.7401365122426904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,18233,194,1.06 [0.92-1.21],0.4092001248653241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,18138,192,0.83 [0.64-1.08],0.1606559403599691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,18233,194,0.96 [0.74-1.24],0.7320989978700141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,15627,160,1.07 [0.90-1.27],0.4424493108720366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,18553,197,1.00 [0.86-1.16],0.9823063331859304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,18290,196,0.76 [0.47-1.22],0.2529427038856401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,16132,167,1.07 [0.88-1.32],0.4889216423038169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18466,193,1.37 [0.71-2.63],0.3473945280446693
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,15625,163,1.06 [0.91-1.24],0.4384306061432097
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18627,198,1.13 [0.71-1.81],0.6107573762569077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,18728,202,1.21 [0.80-1.84],0.3627898109326612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,15554,161,1.08 [0.92-1.27],0.3487127384025965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,18727,200,0.95 [0.76-1.19],0.6578388865901426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,15627,160,1.00 [0.59-1.70],0.9922205736122296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,18603,198,0.99 [0.79-1.24],0.9217786164213192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,18755,200,1.13 [0.81-1.57],0.4579796854647202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,16091,168,0.97 [0.60-1.59],0.9192632638634176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,18233,194,0.96 [0.86-1.07],0.4445460758904518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,15661,160,1.61 [0.93-2.80],0.0910384761742629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,16113,168,1.38 [0.93-2.04],0.1084139050063504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,18466,193,1.37 [1.12-1.68],0.002552295179629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,16132,167,1.03 [0.84-1.27],0.7538732998334956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,18466,193,0.99 [0.76-1.31],0.9703398459550944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,15833,164,1.19 [0.96-1.48],0.1144302648844523
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,18466,193,1.06 [0.91-1.24],0.452106077945799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,16057,169,1.07 [0.92-1.25],0.3828002051516722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,18466,193,1.09 [0.93-1.28],0.3024300073922581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,16057,169,1.22 [0.83-1.80],0.3120817757443648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15585,161,1.23 [0.81-1.88],0.3288680527676835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,16057,169,0.86 [0.67-1.11],0.2393250066810828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18538,198,1.25 [0.92-1.69],0.1568557951339698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18533,200,1.07 [0.88-1.31],0.5013605887039256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,16084,168,1.04 [0.71-1.54],0.8266695897332521
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,18163,194,1.01 [0.79-1.30],0.9237311130272048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,15833,164,0.92 [0.63-1.34],0.6481171471222354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18233,194,1.02 [0.82-1.27],0.8384074421305692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18728,202,1.08 [0.91-1.29],0.3750636119787044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,18138,192,1.02 [0.67-1.56],0.9299801599805484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15754,159,1.14 [0.88-1.48],0.3240825092411352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,18714,201,0.96 [0.71-1.29],0.7623465611022835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,15554,161,1.15 [0.98-1.35],0.0928807466078558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,18343,192,1.10 [0.80-1.52],0.5637366448021305
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,16091,168,0.88 [0.62-1.25],0.4783936668240806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,18792,201,0.95 [0.80-1.12],0.5206274575843227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18561,199,0.92 [0.66-1.29],0.6431709202494125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,18250,194,0.96 [0.79-1.18],0.7184858730914869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,18233,194,1.04 [0.91-1.19],0.5388969789943292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,18163,194,0.94 [0.81-1.09],0.4131877431161239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,16084,168,1.08 [0.90-1.31],0.4130903572221384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,15627,160,1.09 [0.86-1.39],0.4609041363339828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,16057,169,1.18 [0.81-1.72],0.3858172743271428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,15721,168,1.04 [0.80-1.35],0.7790745715583854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,18699,198,1.17 [0.96-1.43],0.1167838946741024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17624,190,1.24 [0.90-1.72],0.1953393133623563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18338,192,0.94 [0.68-1.29],0.6902515778324183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18559,197,0.92 [0.63-1.34],0.6590365703578149
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,18737,201,1.18 [0.81-1.71],0.3891971250573283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,18250,194,1.31 [0.86-2.02],0.2111609639667202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18405,192,1.12 [0.88-1.43],0.3394794502211091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,18737,201,1.11 [0.89-1.38],0.3634852257036809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,18703,200,1.57 [1.08-2.27],0.0176191639183002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,15627,160,1.13 [0.87-1.46],0.3682885031009532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,18603,198,1.08 [0.96-1.21],0.2217506047047064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,18163,194,1.16 [0.84-1.60],0.3788868252897504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,16084,168,1.16 [0.67-2.01],0.5872277536593269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",16059,167,1.03 [0.93-1.14],0.5343220583878094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,18466,193,1.03 [0.92-1.16],0.5655558958801133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,16057,169,0.89 [0.56-1.42],0.6240952341719048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,15585,161,1.06 [0.83-1.35],0.6358553175457191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,18250,194,1.04 [0.89-1.21],0.6283514864178324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,15754,159,1.17 [0.95-1.43],0.143456658915885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,15627,160,1.00 [0.58-1.72],0.9936199895377362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15627,160,1.16 [0.81-1.65],0.413762886827097
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,18138,192,1.25 [1.06-1.47],0.0083624869337322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18233,194,1.17 [0.88-1.54],0.2781309780657017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15585,161,1.08 [0.85-1.37],0.5081124627215263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,16059,167,1.01 [0.85-1.19],0.9476198285367748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,16084,168,1.37 [1.00-1.86],0.0477978320904987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,15627,160,0.99 [0.65-1.50],0.952702675705706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,15833,164,0.85 [0.64-1.11],0.2305727978814815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,16057,169,1.10 [0.93-1.31],0.2619461138969611
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,16059,167,1.09 [0.88-1.34],0.4311226771656415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,16057,169,1.09 [0.84-1.42],0.5044905249791178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,15661,160,1.01 [0.96-1.07],0.6543349832685459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,15554,161,1.30 [0.90-1.89],0.1614628228333094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,15625,163,1.00 [0.85-1.17],0.9949696628811754
